Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  COVID-19

  Free Subscription


Articles published in J Med Virol

Retrieve available abstracts of 756 articles:
HTML format



Single Articles


    November 2020
  1. HENRIQUEZ-MARQUEZ KI, Lainez-Murillo DC, Sierra M, Munoz-Lara F, et al
    High impact of SARS-CoV-2/COVID-19 in the Honduran Health Personnel.
    J Med Virol. 2020 Nov 28. doi: 10.1002/jmv.26702.
    PubMed     Abstract available


  2. ALIZADEHSANI R, Sani ZA, Behjati M, Roshanzamir Z, et al
    Risk Factors Prediction, Clinical Outcomes and Mortality of COVID-19 Patients.
    J Med Virol. 2020 Nov 28. doi: 10.1002/jmv.26699.
    PubMed     Abstract available


  3. LUCIANI M, Bentivegna E, Spuntarelli V, Lamberti PA, et al
    Recurrent Covid-19 Pneumonia in the course of chemotherapy: consequence of a weakened immune system?
    J Med Virol. 2020 Nov 28. doi: 10.1002/jmv.26701.
    PubMed     Abstract available


  4. HARIYANTO TI, Kurniawan A
    Tocilizumab administration is associated with reduction in biomarkers of coronavirus disease 2019 (COVID-19) infection.
    J Med Virol. 2020 Nov 26. doi: 10.1002/jmv.26698.
    PubMed     Abstract available


  5. VALDIVIA A, Torres I, Latorre V, Frances-Gomez C, et al
    Suitability of Two Rapid Lateral Flow Immunochromatographic Assays for Predicting SARS-CoV-2 Neutralizing Activity of Sera.
    J Med Virol. 2020 Nov 25. doi: 10.1002/jmv.26697.
    PubMed     Abstract available


  6. KANG K, Huang L, Ouyang C, Du J, et al
    Development, Performance Evaluation and Clinical Application of A Rapid SARS-CoV-2 IgM and IgG Test Kit Based on Automated Fluorescence Immunoassay.
    J Med Virol. 2020 Nov 24. doi: 10.1002/jmv.26696.
    PubMed     Abstract available


  7. ZHANG G, Wu Y, Xu R, Du X, et al
    Effects of Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors on Disease Severity and Mortality in Patients with COVID-19: A Meta-analysis.
    J Med Virol. 2020 Nov 24. doi: 10.1002/jmv.26695.
    PubMed     Abstract available


  8. AWAN UA, Zahoor S, Rehman K, Khattak AA, et al
    COVID-19 and Influenza H1N1: A dangerous combination for Pakistan in the upcoming winter season.
    J Med Virol. 2020 Nov 24. doi: 10.1002/jmv.26687.
    PubMed     Abstract available


  9. DESMET S, Ekinci E, Wouters I, Decru B, et al
    No SARS-CoV-2 carriage observed in children attending daycare centers during the first weeks of the epidemic in Belgium.
    J Med Virol. 2020 Nov 24. doi: 10.1002/jmv.26689.
    PubMed     Abstract available


  10. GARG A, Ghoshal U, Patel SS, Singh DV, et al
    Evaluation of seven commercial RT-PCR kits for COVID-19 testing in pooled clinical specimens.
    J Med Virol. 2020 Nov 24. doi: 10.1002/jmv.26691.
    PubMed     Abstract available


  11. BOSCHI C, Hoang VT, Giraud-Gatineau A, Ninove L, et al
    Co-infections with SARS-CoV-2 and other respiratory viruses in Southeastern France: a matter of sampling time.
    J Med Virol. 2020 Nov 24. doi: 10.1002/jmv.26692.
    PubMed     Abstract available


  12. OZSUREKCI Y, Aykac K, Er AG, Halacli B, et al
    Predictive Value of Cytokine/Chemokine Responses for the Disease Severity and Management in Children and Adult Cases with COVID-19.
    J Med Virol. 2020 Nov 23. doi: 10.1002/jmv.26683.
    PubMed     Abstract available


  13. ALSHARRAH D, Alhaddad F, Alyaseen M, Aljamaan S, et al
    Clinical Characteristics of Pediatric SARS-CoV-2 Infection and Coronavirus Disease 2019 (COVID-19) in Kuwait.
    J Med Virol. 2020 Nov 20. doi: 10.1002/jmv.26684.
    PubMed     Abstract available


  14. GIULIANI J, Bonetti A
    COVID-19 and Cancer: A Clear Change Not Only in Daily Clinical Practice But Also in Clinical Research Management.
    J Med Virol. 2020 Nov 20. doi: 10.1002/jmv.26680.
    PubMed     Abstract available


  15. AKINOSOGLOU K, Gogos A, Papageorgiou C, Angelopoulos E, et al
    Ketamine in COVID-19 patients: Thinking out of the box.
    J Med Virol. 2020 Nov 20. doi: 10.1002/jmv.26681.
    PubMed     Abstract available


  16. TAKAGI H
    A red mirage - Did the association of the 2016 presidential election results with the COVID-19 epidemic magically disappear in 2020?
    J Med Virol. 2020 Nov 20. doi: 10.1002/jmv.26682.
    PubMed     Abstract available


  17. VERALDI S, Spigariolo CB
    Pityriasis rosea and COVID-19.
    J Med Virol. 2020 Nov 18. doi: 10.1002/jmv.26679.
    PubMed     Abstract available


  18. MERCATELLI D, Triboli L, Fornasari E, Ray F, et al
    coronapp: A Web Application to Annotate and Monitor SARS-CoV-2 Mutations.
    J Med Virol. 2020 Nov 18. doi: 10.1002/jmv.26678.
    PubMed     Abstract available


  19. FAVRESSE J, Cadrobbi J, Eucher C, Elsen M, et al
    Clinical performances of three fully automated anti-SARS-CoV-2 immunoassays targeting the nucleocapsid or spike proteins.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26669.
    PubMed     Abstract available


  20. HILL JA, Menon MP, Dhanireddy S, Wurfel MM, et al
    Tocilizumab in hospitalized patients with COVID-19: Clinical outcomes, inflammatory marker kinetics, and safety.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26674.
    PubMed     Abstract available


  21. YANG J, Tian C, Chen Y, Zhu C, et al
    Obesity aggravates COVID-19: an updated systematic review and meta-analysis.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26677.
    PubMed     Abstract available


  22. SPOTO S, Agro FE, Sambuco F, Travaglino F, et al
    High value of Mid-regional proAdrenomedullin in COVID-19: a marker of widespread endothelial damage, disease severity and mortality.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26676.
    PubMed     Abstract available


  23. SWAMINATHAN N, Moussa P, Mody N, Bryan Lo K, et al
    COVID-19 in HIV infected patients: A Case series and Literature Review.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26671.
    PubMed     Abstract available


  24. AWAN UA, Zahoor S, Ayub A, Ahmed H, et al
    COVID-19 and Arboviral Diseases: Another Challenge for Pakistan's Delipidated Healthcare System.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26668.
    PubMed    


  25. ATEYA AM, Sabri NA
    Angiotensin-converting enzyme inhibitors (ACEIs) and Angiotensin-receptor blockers (ARBs) benefits outweigh the risks in COVID-19 hypertensive patients.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26672.
    PubMed     Abstract available


  26. SEYMEN CM
    The other side of COVID-19 pandemic: Effects on male fertility.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26667.
    PubMed     Abstract available


  27. SYAL K
    Newly identified limitations of diagnostic tools for COVID-19 and consequences.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26673.
    PubMed     Abstract available


  28. WANG J, Zhu L, Xue L, Liu L, et al
    Risk factors of liver injury in patients with coronavirus disease 2019 in Jiangsu, China: a retrospective, multi-center study.
    J Med Virol. 2020 Nov 11. doi: 10.1002/jmv.26663.
    PubMed     Abstract available


  29. SHARMA B
    Does use of propofol aggravate the inflammatory markers and cause propofol infusion syndrome (PRIS) in intubated cases of severe COVID-19 infections?
    J Med Virol. 2020 Nov 9. doi: 10.1002/jmv.26657.
    PubMed     Abstract available


  30. LARROSA JMC
    Sars-Cov-2 in Argentina: Lockdown, Mobility, and Contagion.
    J Med Virol. 2020 Nov 9. doi: 10.1002/jmv.26659.
    PubMed     Abstract available


  31. HO YI, Wong AH, Leung EC, Wong RC, et al
    Rapid adaptation and continuous performance evaluation of SARS-CoV-2 envelope gene (E-gene) real-time RT-PCR assays to support the hospital surge in test demand.
    J Med Virol. 2020 Nov 9. doi: 10.1002/jmv.26660.
    PubMed     Abstract available


  32. TAKAGI H
    Survey of COVID-19 dynamics across US states.
    J Med Virol. 2020 Nov 9. doi: 10.1002/jmv.26658.
    PubMed     Abstract available


  33. MONREAL E, de la Maza SS, Gullon P, Natera-Villalba E, et al
    Non-severe immunosuppression might be associated with a lower risk of moderate-severe acute respiratory distress syndrome in COVID-19: a pilot study.
    J Med Virol. 2020 Nov 9. doi: 10.1002/jmv.26656.
    PubMed     Abstract available


  34. SAID EA, Al-Reesi I, Al-Shizawi N, Jaju S, et al
    Defining IL-6 Levels in Healthy Individuals: A Meta-Analysis.
    J Med Virol. 2020 Nov 6. doi: 10.1002/jmv.26654.
    PubMed     Abstract available


  35. HAN X, Ye Q
    Kidney involvement in COVID-19 and its treatments.
    J Med Virol. 2020 Nov 5. doi: 10.1002/jmv.26653.
    PubMed     Abstract available


  36. MASCOLO S, Carleo MA, Contieri M, Izzo S, et al
    SARS-CoV-2 and inflammatory responses: from mechanisms to the potential therapeutic use of intravenous immunoglobulin.
    J Med Virol. 2020 Nov 5. doi: 10.1002/jmv.26651.
    PubMed     Abstract available


  37. LIN SF, Lai CC, Chao CM, Tang HJ, et al
    Impact of COVID-19 preventative measures on dengue infections in Taiwan.
    J Med Virol. 2020 Nov 3. doi: 10.1002/jmv.26650.
    PubMed     Abstract available


  38. ALBERT E, Bracho MA, Serrano A, Ferrer B, et al
    Assessing the potential association between SARS-CoV-2 RNA load in the respiratory tract and COVID-19 mortality.
    J Med Virol. 2020 Nov 2. doi: 10.1002/jmv.26644.
    PubMed     Abstract available


  39. OZCELIK N, Ozyurt S, Yilmaz Kara B, Gumus A, et al
    The Value of Platelet Count and Platelet Indices in Differentiation of COVID-19 and Influenza Pneumonia.
    J Med Virol. 2020 Nov 2. doi: 10.1002/jmv.26645.
    PubMed     Abstract available


  40. LIU C, Yu X, Gao C, Zhang L, et al
    Characterization of Antibody Responses to SARS-CoV-2 in Convalescent COVID-19 Patients.
    J Med Virol. 2020 Nov 2. doi: 10.1002/jmv.26646.
    PubMed     Abstract available


  41. HOANG T
    Systematic review and meta-analysis of factors associated with re-positive viral RNA after recovery from COVID-19.
    J Med Virol. 2020 Nov 2. doi: 10.1002/jmv.26648.
    PubMed     Abstract available


    October 2020
  42. ALSHARIF KF, Alzahrani AB, Alharbi AO, Algregri TO, et al
    The prevalence of MERS-CoV among military personnel and their families: A single center study.
    J Med Virol. 2020 Oct 31. doi: 10.1002/jmv.26642.
    PubMed     Abstract available


  43. PENROD Y, Garcia D, Dunn ST
    Evaluation of transport media for laboratory detection of SARS-CoV-2 in upper respiratory tract swab specimens.
    J Med Virol. 2020 Oct 31. doi: 10.1002/jmv.26643.
    PubMed     Abstract available


  44. KOW CS, Aldeyab M, Hasan SS
    Effect of remdesivir on mortality in patients with COVID-19: A meta-analysis of randomized control trials.
    J Med Virol. 2020 Oct 29. doi: 10.1002/jmv.26638.
    PubMed     Abstract available


  45. TORRES DA, Ribeiro LDCB, Riello APFL, Horovitz DDG, et al
    Reinfection of COVID-19 after 3 months with a distinct and more aggressive clinical presentation: case report.
    J Med Virol. 2020 Oct 28. doi: 10.1002/jmv.26637.
    PubMed     Abstract available


  46. ARAIMO F, Imperiale C, Tordiglione P, Ceccarelli G, et al
    Ozone as Adjuvant Support in the Treatment of COVID-19: A Preliminary Report of Probiozovid Trial.
    J Med Virol. 2020 Oct 28. doi: 10.1002/jmv.26636.
    PubMed     Abstract available


  47. ZHANG C, Wu Z, Li JW, Tan K, et al
    Discharge may not be the end of treatment: pay attention to pulmonary fibrosis caused by severe COVID-19.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26634.
    PubMed     Abstract available


  48. RAGAB D, Salah Eldin H, Afify M, Soliman W, et al
    A case of COVID-19, with cytokine storm, treated by consecutive use of therapeutic plasma exchange followed by convalescent plasma transfusion: a case report.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26630.
    PubMed     Abstract available


  49. MENG M, Zhou X, Zhang Q, Zou J, et al
    The positive rate of saliva for the detection of 2019-nCoV and possible factors related to the sensitivity results.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26627.
    PubMed     Abstract available


  50. BISHBURG E, Okoh A, Nagarakanti SR, Lindner M, et al
    Fungemia in COVID -19 ICU Patients, a Single Medical Center Experience.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26633.
    PubMed     Abstract available


  51. CHEN F, Geng Z, Wang J, Liuchang W, et al
    Comparing two sample pooling strategies for SARS-CoV-2 RNA detection for efficient screening of COVID-19.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26632.
    PubMed     Abstract available


  52. TORTAJADA C, Colomer E, Andreu-Ballester JC, Esparcia A, et al
    Corticosteroids for COVID-19 patients requiring oxygen support? Yes, but not for everyone: Effect of corticosteroids on mortality and Intensive Care Unit admission in patients with COVID-19 according to patients' oxygen requirements.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26635.
    PubMed     Abstract available


  53. YAZIHAN N, Tanacan A, Erol SA, Anuk AT, et al
    Comparison of VEGF-A Values between Pregnant Women with COVID-19 and Healthy Pregnancies and Its Association with Composite Adverse Outcomes.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26631.
    PubMed     Abstract available


  54. BOUASSA RM, Pere H, Tonen-Wolyec S, Longo JD, et al
    Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points IgM as Achilles heel.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26628.
    PubMed     Abstract available


  55. WANG Y, Chen B, Li Y, Zhang L, et al
    The Use of Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors is Associated with a Lower Risk of Mortality in Hypertensive COVID-19 Patients: A Systematic Review and Meta-analysis.
    J Med Virol. 2020 Oct 23. doi: 10.1002/jmv.26625.
    PubMed     Abstract available


  56. BAIG AM
    Chronic COVID Syndrome: Need for an appropriate medical terminology for Long-COVID and COVID Long-Haulers.
    J Med Virol. 2020 Oct 23. doi: 10.1002/jmv.26624.
    PubMed     Abstract available


  57. SHAMINUR RAHMAN M, Rafiul Islam M, Rubayet Ul Alam ASM, Islam I, et al
    Evolutionary dynamics of SARS-CoV-2 nucleocapsid (N) protein and its consequences.
    J Med Virol. 2020 Oct 23. doi: 10.1002/jmv.26626.
    PubMed     Abstract available


  58. BWIRE GM, Njiro BJ, Mwakawanga DL, Sabas D, et al
    Possible vertical transmission and antibodies against SARS-CoV-2 among infants born to mothers with COVID-19: A living systematic review.
    J Med Virol. 2020 Oct 22. doi: 10.1002/jmv.26622.
    PubMed     Abstract available


  59. TAKAGI H
    Presidential vote 2016 and COVID-19 epidemic.
    J Med Virol. 2020 Oct 22. doi: 10.1002/jmv.26620.
    PubMed     Abstract available


  60. SREENIVASAN CC, Thomas M, Wang D, Li F, et al
    Susceptibility of livestock and companion animals to COVID-19.
    J Med Virol. 2020 Oct 22. doi: 10.1002/jmv.26621.
    PubMed     Abstract available


  61. MOHANTY S, Ravindra A, Gupta K, Hallur V, et al
    Intricacies in characterizing positivity in pooled sample testing for SARS-CoV-2.
    J Med Virol. 2020 Oct 21. doi: 10.1002/jmv.26618.
    PubMed     Abstract available


  62. CHEN Y, Ke Y, Liu X, Wang Z, et al
    Clinical features and antibody response of patients from a COVID-19 treatment hospital in Wuhan, China.
    J Med Virol. 2020 Oct 21. doi: 10.1002/jmv.26617.
    PubMed     Abstract available


  63. MATTOS EC, Matsuda EM, Colpas DR, Carvalho F, et al
    Can urine be a potential biohazard in times of SARS-CoV-2 pandemic?
    J Med Virol. 2020 Oct 21. doi: 10.1002/jmv.26616.
    PubMed     Abstract available


  64. KUMAR A, Prasoon P, Kumari C, Pareek V, et al
    SARS-CoV-2 specific virulence factors in COVID-19.
    J Med Virol. 2020 Oct 21. doi: 10.1002/jmv.26615.
    PubMed     Abstract available


  65. KIVELA JM, Jarva H, Lappalainen M, Kurkela S, et al
    Saliva-based testing for diagnosis of SARS-CoV-2 infection: A meta-analysis.
    J Med Virol. 2020 Oct 20. doi: 10.1002/jmv.26613.
    PubMed     Abstract available


  66. SELINGEROVA I, Valik D, Gescheidtova L, Sramek V, et al
    Interpretive discrepancies caused by target values inter-batch variations in chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG by MAGLUMI.
    J Med Virol. 2020 Oct 20. doi: 10.1002/jmv.26612.
    PubMed     Abstract available


  67. YUN HE, Ryu BY, Choe YJ
    Impact of Social Distancing on Incidence of Vaccine-Preventable Diseases, South Korea.
    J Med Virol. 2020 Oct 20. doi: 10.1002/jmv.26614.
    PubMed     Abstract available


  68. CAVALIERE AF, Marchi L, Aquilini D, Brunelli T, et al
    Passive Immunity in Newborn from SARS-CoV-2 Infected Mother.
    J Med Virol. 2020 Oct 19. doi: 10.1002/jmv.26609.
    PubMed     Abstract available


  69. YANG P, Wang N, Wang J, Luo A, et al
    Admission fasting plasma glucose is an independent risk factor for 28-day mortality in patients with COVID-19.
    J Med Virol. 2020 Oct 19. doi: 10.1002/jmv.26608.
    PubMed     Abstract available


  70. STRATTON CW, Tang YW, Lu H
    Pathogenesis-Directed Therapy of 2019 Novel Coronavirus Disease.
    J Med Virol. 2020 Oct 19. doi: 10.1002/jmv.26610.
    PubMed     Abstract available


  71. CRISCUOLO E, Diotti RA, Strollo M, Rolla S, et al
    Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects.
    J Med Virol. 2020 Oct 16. doi: 10.1002/jmv.26605.
    PubMed     Abstract available


  72. YIGENOGLU TN, Basci S, Sinan Dal M, Korkmaz S, et al
    The outcome of COVID-19 in patients with hematological malignancy.
    J Med Virol. 2020 Oct 16. doi: 10.1002/jmv.26607.
    PubMed     Abstract available


  73. SILVA JUNIOR JVJ, Lopes TRR, Weiblen R, Flores EF, et al
    Background immunity: how important is it for SARS-CoV-2?
    J Med Virol. 2020 Oct 15. doi: 10.1002/jmv.26602.
    PubMed     Abstract available


  74. YAZDANPANAH Y
    Impact on disease mortality of clinical, biological and virological characteristics at hospital admission and over time in COVID-19 patients.
    J Med Virol. 2020 Oct 15. doi: 10.1002/jmv.26601.
    PubMed     Abstract available


  75. HE J, Huang F, Zhang J, Chen Q, et al
    Vaccine design based on 16 epitopes of SARS-CoV-2 spike protein.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26596.
    PubMed     Abstract available


  76. HIGUCHI T, Nishida T, Iwahashi H, Morimura O, et al
    Early Clinical Factors Predicting the Development of Critical Disease in Japanese Patients with COVID-19: A Single-Center, Retrospective, Observational Study.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26599.
    PubMed     Abstract available


  77. ROSEN HR, O'Connell C, Nadim MK, DeClerck B, et al
    Extrapulmonary Manifestations of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26595.
    PubMed     Abstract available


  78. WU S, Tian C, Liu P, Guo D, et al
    Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26597.
    PubMed     Abstract available


  79. PODDER S, Ghosh A, Ghosh T
    Mutations in membrane-fusion subunit of spike glycoprotein play crucial role in the recent outbreak of COVID-19.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26598.
    PubMed     Abstract available


  80. HERNANDEZ-HUERTA MT, Mayoral LP, Diaz CR, Cruz MM, et al
    Analysis of SARS-CoV-2 mutations in Mexico, Belize and isolated regions of Guatemala and its implication in the diagnosis.
    J Med Virol. 2020 Oct 13. doi: 10.1002/jmv.26591.
    PubMed     Abstract available


  81. MANSOOR SR, Ghasemi-Kasman M
    Impact of disease-modifying drugs on severity of COVID-19 infection in multiple sclerosis patients.
    J Med Virol. 2020 Oct 12. doi: 10.1002/jmv.26593.
    PubMed     Abstract available


  82. DAUNT A, Perez-Guzman PN, Cafferkey J, Manalan K, et al
    Factors associated with re-attendance to emergency services following COVID-19 hospitalisation.
    J Med Virol. 2020 Oct 12. doi: 10.1002/jmv.26594.
    PubMed     Abstract available


  83. YOKOYAMA Y, Aikawa T, Takagi H, Briasoulis A, et al
    Association of Renin-Angiotensin-Aldosterone System Inhibitors with Mortality and Testing Positive of COVID-19; Meta-Analysis.
    J Med Virol. 2020 Oct 10. doi: 10.1002/jmv.26588.
    PubMed     Abstract available


  84. CHIRUMBOLO S
    SARS-CoV2 virions in PM10 pollutants. May further research reject this thesis?
    J Med Virol. 2020 Oct 10. doi: 10.1002/jmv.26590.
    PubMed     Abstract available


  85. KERGET B, Kerget F, Aksakal A, Askin S, et al
    Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome.
    J Med Virol. 2020 Oct 10. doi: 10.1002/jmv.26589.
    PubMed     Abstract available


  86. HALPIN S, O'Connor R, Sivan M
    Long COVID and chronic COVID syndromes.
    J Med Virol. 2020 Oct 9. doi: 10.1002/jmv.26587.
    PubMed     Abstract available


  87. SPEROTTO A, Candoni A, Petruzzellis G, Mullai R, et al
    Screening Procedure for SARS-CoV-2 infection combining Triage, nasopharyngeal swab and serological test in allogeneic stem cell transplantation Recipients Undergoing Outpatient Post Transplant Follow-Up.
    J Med Virol. 2020 Oct 8. doi: 10.1002/jmv.26586.
    PubMed     Abstract available


  88. LENG Y, Chen M, Dai M, Wu Y, et al
    Minimize glycemic fluctuation decrease the risk of severe illness and death in patients with COVID-19.
    J Med Virol. 2020 Oct 7. doi: 10.1002/jmv.26584.
    PubMed     Abstract available


  89. PEZZUTO A, Tammaro A, Tonini G, Ciccozzi M, et al
    COPD influences survival in patients affected by Covid-19, comparison between subjects admitted to an internal medicine unit and subjects admitted to an intensive care unit :an Italian experience.
    J Med Virol. 2020 Oct 7. doi: 10.1002/jmv.26585.
    PubMed     Abstract available


  90. YUEN CK, Wong WM, Mak LF, Wang X, et al
    Suppression of SARS-CoV-2 infection in ex-vivo human lung tissues by targeting class III phosphoinositide 3-kinase.
    J Med Virol. 2020 Oct 7. doi: 10.1002/jmv.26583.
    PubMed     Abstract available


  91. FINSTERER J, Stollberger C
    SARS-CoV-2 triggered Takotsubo in 38 patients.
    J Med Virol. 2020 Oct 6. doi: 10.1002/jmv.26581.
    PubMed     Abstract available


  92. HUANG F, Liu X, Sun X, Li Z, et al
    IL-10 served as an indicator in severe COVID-19 patients.
    J Med Virol. 2020 Oct 6. doi: 10.1002/jmv.26580.
    PubMed     Abstract available


  93. URRA JM, Ferreras-Colino E, Contreras M, Cabrera CM, et al
    The antibody response to the glycan alpha-Gal correlates with COVID-19 disease symptoms.
    J Med Virol. 2020 Oct 3. doi: 10.1002/jmv.26575.
    PubMed     Abstract available


  94. CAKIR B
    The outcome of COVID-19 in patients with hematological malignancy.
    J Med Virol. 2020 Oct 2. doi: 10.1002/jmv.26576.
    PubMed     Abstract available


  95. D'ALESSANDRO M, Bergantini L, Cameli P, Curatola G, et al
    Peripheral biomarkers' panel for severe COVID-19 patients.
    J Med Virol. 2020 Oct 2. doi: 10.1002/jmv.26577.
    PubMed     Abstract available


  96. LIU JM, Tan BH, Wu S, Gui Y, et al
    Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement in the lethality of SARS-CoV-2 infection.
    J Med Virol. 2020 Oct 1. doi: 10.1002/jmv.26570.
    PubMed     Abstract available


    September 2020
  97. GUMUS T, Cengiz D, Kartal F, Atceken Z, et al
    Changes in Computed Tomography Findings of COVID-19 Pneumonia: Less Extensive Lung Involvement with Decreasing Disease Prevalence.
    J Med Virol. 2020 Sep 30. doi: 10.1002/jmv.26573.
    PubMed     Abstract available


  98. WONG RC, Wong AH, Ho YI, Leung EC, et al
    Performance evaluation of Panther Fusion SARS-CoV-2 assay for detection of SARS-CoV-2 from deep throat saliva, nasopharyngeal and lower-respiratory-tract specimens.
    J Med Virol. 2020 Sep 30. doi: 10.1002/jmv.26574.
    PubMed     Abstract available


  99. CHEN Y, Linli Z, Lei Y, Yang Y, et al
    Risk Factors for Mortality in Critically Ill Patients with COVID-19 in Huanggang, China: A Single-Centre Multivariate Pattern Analysis.
    J Med Virol. 2020 Sep 30. doi: 10.1002/jmv.26572.
    PubMed     Abstract available


  100. RANA MS, Alam MM, Ikram A, Zaidi SSZ, et al
    Co-circulation of COVID-19 and dengue: A perspective from Pakistan.
    J Med Virol. 2020 Sep 29. doi: 10.1002/jmv.26567.
    PubMed     Abstract available


  101. ZHAO Y, He J, Wang J, Li WM, et al
    Development of Pancytopenia in a Patient with COVID-19.
    J Med Virol. 2020 Sep 29. doi: 10.1002/jmv.26566.
    PubMed     Abstract available


  102. BONGIOVANNI M
    COVID-19 re-infection in an healthcare worker.
    J Med Virol. 2020 Sep 29. doi: 10.1002/jmv.26565.
    PubMed     Abstract available


  103. MANDAL AKJ, Baktash V, Hosack T, Van den Abbeele K, et al
    Vitamin D status may indeed be a prognosticator for morbidity and mortality in patients with COVID-19.
    J Med Virol. 2020 Sep 29. doi: 10.1002/jmv.26569.
    PubMed     Abstract available


  104. HU J, Li S, Wu Y, Xiong Z, et al
    Surveillance and re-Positive RNA test in Patients recovered from COVID-19.
    J Med Virol. 2020 Sep 29. doi: 10.1002/jmv.26568.
    PubMed     Abstract available


  105. ROMERO-LOPEZ JP, Carnalla-Cortes M, Pacheco-Olvera DL, Ocampo-Godinez JM, et al
    A bioinformatic prediction of antigen presentation from SARS-CoV-2 spike protein revealed a theorical correlation of HLA-DRB1*01 with COVID-19 fatality in Mexican population: an ecological approach.
    J Med Virol. 2020 Sep 28. doi: 10.1002/jmv.26561.
    PubMed     Abstract available


  106. ALMAGHLOUTH NK, Davis MG, Davis MA, Anyiam FE, et al
    Risk factors for mortality among patients with SARS-CoV-2 infection: A longitudinal observational study.
    J Med Virol. 2020 Sep 28. doi: 10.1002/jmv.26560.
    PubMed     Abstract available


  107. HAUSLER M, van Helden J, Kleines M
    Retarded decline of the share of SARS-CoV-2-positive children in North Rhine-Westphalia, Germany.
    J Med Virol. 2020 Sep 28. doi: 10.1002/jmv.26564.
    PubMed     Abstract available


  108. TAKAGI H
    Government's policy, citizens' behavior, and COVID-19 pandemic.
    J Med Virol. 2020 Sep 26. doi: 10.1002/jmv.26559.
    PubMed     Abstract available


  109. SAFARI I, InanlooRahatloo K, Elahi E
    11Evolution of SARS-CoV-2 genome from December 2019 to late March 2020: emerged haplotypes and informative Tag nucleotide variations.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26553.
    PubMed     Abstract available


  110. GUDMUNDSDOTTIR A, Scheving R, Lindberg F, Stefansson B, et al
    Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme(R) a medical device mouth spray against common cold.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26554.
    PubMed     Abstract available


  111. MONDI A, Cimini E, Colavita F, Cicalini S, et al
    COVID-19 in people living with HIV: clinical implications of dynamics of immune response to SARS-CoV-2.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26556.
    PubMed     Abstract available


  112. XU R, Cui J, Hu L, Wang Y, et al
    Development and validation of a simplified nomogram predicting individual critical illness of risk in COVID-19: a retrospective study.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26551.
    PubMed     Abstract available


  113. FINSTERER J, Scorza FA
    SARS-CoV-2 myopathy.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26550.
    PubMed     Abstract available


  114. MALIK P, Patel U, Patel K, Martin M, et al
    Obesity a predictor of outcomes of COVID-19 hospitalized patients- A systematic Review and Meta-Analysis.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26555.
    PubMed     Abstract available


  115. LO YL
    Covid-19, fatigue and dysautonomia.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26552.
    PubMed     Abstract available


  116. BADUA CLDC, Baldo KAT, Medina PMB
    Genomic and Proteomic Mutation Landscapes of SARS-CoV-2.
    J Med Virol. 2020 Sep 24. doi: 10.1002/jmv.26548.
    PubMed     Abstract available


  117. DRAGO F, Ciccarese G, Rebora A, Parodi A, et al
    Human herpesvirus 6, 7 and Epstein Barr virus reactivation in pityriasis rosea during COVID-19.
    J Med Virol. 2020 Sep 24. doi: 10.1002/jmv.26549.
    PubMed     Abstract available


  118. AMBADE V
    Biochemical rationale for hypoalbuminemia in COVID-19 patients.
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26542.
    PubMed     Abstract available


  119. PERESON MJ, Mojsiejczuk L, Martinez AP, Flichman DM, et al
    Phylogenetic analysis of SARS-CoV-2 IN THE FIRST MONTHS SINCE ITS EMERGENCE.
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26545.
    PubMed     Abstract available


  120. GONCHAROVA EA, Dedkov VG, Dolgova AS, Kassirov IS, et al
    One-Step Quantitative RT-PCR Assay with Armored RNA Controls for Detection of SARS-CoV-2.
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26540.
    PubMed     Abstract available


  121. YASRI S, Wiwanitkit V
    Systemic lupus erythematosus, varicella-like rash and COVID-19.
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26547.
    PubMed     Abstract available


  122. LIPPI G, Mattiuzzi C
    Clinical value anti-SARS-COV-2 serum IgA titration in patients with COVID-19.
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26539.
    PubMed     Abstract available


  123. OMRANI AS, Zaqout A, Baiou A, Daghfal J, et al
    Convalescent Plasma for the Treatment of Patients with Severe Coronavirus Disease 2019; a Preliminary Report.
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26537.
    PubMed     Abstract available


  124. TURAL ONUR S, Altin S, Nedime Sokucu S, Ileri Fikri B, et al
    Could ferritin level be an indicator of COVID-19 disease mortality?
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26543.
    PubMed     Abstract available


  125. YUE L, Cao H, Xie T, Long R, et al
    N-terminally truncated nucleocapsid protein of SARS-CoV-2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactive SARS-CoV-2.
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26541.
    PubMed     Abstract available


  126. YAN H, Lu S, Chen L, Wang Y, et al
    Multiple Organ Injury on Admission Predicts In-Hospital Mortality in Patients with COVID -19.
    J Med Virol. 2020 Sep 19. doi: 10.1002/jmv.26534.
    PubMed     Abstract available


  127. SILVA SJRD, Pena L
    A Word of Caution in Interpreting Covid-19 Diagnostics Tests.
    J Med Virol. 2020 Sep 19. doi: 10.1002/jmv.26531.
    PubMed    


  128. BENOIT JL, Benoit SW, Oliveira MHS, Lippi G, et al
    Anemia and COVID-19: a prospective perspective.
    J Med Virol. 2020 Sep 19. doi: 10.1002/jmv.26530.
    PubMed    


  129. LI L, Lowe CF, Ritchie G, Stefanovic A, et al
    SARS-CoV-2 molecular testing for the diagnosis of COVID-19: One test does not fit all.
    J Med Virol. 2020 Sep 19. doi: 10.1002/jmv.26532.
    PubMed     Abstract available


  130. AKIYAMA S, Yamada A, Sakuraba A
    Safety of non-tumor necrosis factor-targeted biologics in the COVID-19 pandemic.
    J Med Virol. 2020 Sep 19. doi: 10.1002/jmv.26528.
    PubMed     Abstract available


  131. NAGARAKANTI SR, Okoh AK, Grinberg S, Bishburg E, et al
    Clinical outcomes of patients with COVID-19 and HIV coinfection.
    J Med Virol. 2020 Sep 19. doi: 10.1002/jmv.26533.
    PubMed     Abstract available


  132. FEI F, Smith JA, Cao L
    Clinical laboratory characteristics in patients with suspected COVID-19: one single institution experience.
    J Med Virol. 2020 Sep 18. doi: 10.1002/jmv.26527.
    PubMed     Abstract available


  133. BREWER J, Marti JLG, Brufsky A
    Potential Interventions for SARS-CoV-2 Infections: Zinc Showing Promise.
    J Med Virol. 2020 Sep 17. doi: 10.1002/jmv.26523.
    PubMed     Abstract available


  134. NOROOZNEZHAD AH, Eskandarion S, Akbari R, Alimohammadi S, et al
    Changes of Leukocytes, Neutrophils, and Lymphocytes Count and Dependent Variables in Pregnant Women with Coronavirus Disease 2019 (COVID-19) Before and After Cesarean Delivery.
    J Med Virol. 2020 Sep 17. doi: 10.1002/jmv.26525.
    PubMed     Abstract available


  135. MEYERS C, Robison R, Milici J, Alam S, et al
    Lowering the Transmission and Spread of Human Coronavirus.
    J Med Virol. 2020 Sep 17. doi: 10.1002/jmv.26514.
    PubMed     Abstract available


  136. YANG S, Shan T, Xiao Y, Zhang H, et al
    Digging metagenomic data of pangolins revealed SARS-CoV-2 related viruses and other significant viruses.
    J Med Virol. 2020 Sep 17. doi: 10.1002/jmv.26524.
    PubMed     Abstract available


  137. BATEMAN AC, Mueller S, Guenther K, Shult P, et al
    Assessing the Dilution Effect of Specimen Pooling on the Sensitivity of SARS-CoV-2 PCR Tests.
    J Med Virol. 2020 Sep 16. doi: 10.1002/jmv.26519.
    PubMed     Abstract available


  138. ZHOU P, Li Z, Xie L, An D, et al
    Research progress and challenges to coronavirus vaccine development.
    J Med Virol. 2020 Sep 16. doi: 10.1002/jmv.26517.
    PubMed     Abstract available


  139. DEY J, Alam MT, Chandra S, Gupta J, et al
    Neuroinvasion of SARS-CoV-2 may play a role in the breakdown of respiratory center of the brain.
    J Med Virol. 2020 Sep 16. doi: 10.1002/jmv.26521.
    PubMed     Abstract available


  140. CARUSO A, Caccuri F, Bugatti A, Zani A, et al
    Methotrexate inhibits SARS-CoV-2 virus replication "in vitro".
    J Med Virol. 2020 Sep 14. doi: 10.1002/jmv.26512.
    PubMed     Abstract available


  141. CHEN T, Li G, Liu H, Wan W, et al
    Clinical characteristics of 132 healthcare workers cases with COVID-19: a retrospective study from a single center in Wuhan, China.
    J Med Virol. 2020 Sep 14. doi: 10.1002/jmv.26511.
    PubMed     Abstract available


  142. SLIMANI Y, Abbassi R, El Fatoiki FZ, Barrou L, et al
    Systemic lupus erythematosus and varicella-like rash following COVID-19 in a previously healthy patient.
    J Med Virol. 2020 Sep 14. doi: 10.1002/jmv.26513.
    PubMed     Abstract available


  143. YANG C, Ma X, Wu J, Han J, et al
    Low serum calcium and phosphorus and their clinical performance in detecting COVID-19 patients.
    J Med Virol. 2020 Sep 14. doi: 10.1002/jmv.26515.
    PubMed     Abstract available


  144. AZIZ M, Haghbin H, Sitta EA, Nawras Y, et al
    Efficacy of Tocilizumab in COVID-19: A Systematic review and Meta-Analysis.
    J Med Virol. 2020 Sep 12. doi: 10.1002/jmv.26509.
    PubMed     Abstract available


  145. SPEECKAERT MM, De Buyzere ML, Delanghe JR
    Vitamin D binding protein polymorphism and COVID-19.
    J Med Virol. 2020 Sep 12. doi: 10.1002/jmv.26508.
    PubMed     Abstract available


  146. HENDERSON CE, Rezai S, Jackman JM
    Universal Screening for Novel Coronavirus Disease 2019 (COVID-19) for Asymptomatic Parturients - May Not Be Beneficial At This Time.
    J Med Virol. 2020 Sep 11. doi: 10.1002/jmv.26507.
    PubMed     Abstract available


  147. TAN Y, Zhou J, Zhou Q, Hu L, et al
    Role of Eosinophils in the Diagnosis and Prognostic Evaluation of COVID-19.
    J Med Virol. 2020 Sep 11. doi: 10.1002/jmv.26506.
    PubMed     Abstract available


  148. FINSTERER J, Scorza FA, Scorza CA, Fiorini AC, et al
    SARS-CoV-2 and myasthenia.
    J Med Virol. 2020 Sep 10. doi: 10.1002/jmv.26501.
    PubMed     Abstract available


  149. TAKAGI H
    COVID-19 epidemic and community mobility in Tokyo.
    J Med Virol. 2020 Sep 10. doi: 10.1002/jmv.26502.
    PubMed     Abstract available


  150. TAKAHASHI M, Egorova NN, Kuno T
    COVID-19 and influenza testing in New York City.
    J Med Virol. 2020 Sep 10. doi: 10.1002/jmv.26500.
    PubMed     Abstract available


  151. ZHANG B, Yue D, Wang Y, Wang F, et al
    The dynamics of immune response in COVID-19 patients with different illness severity.
    J Med Virol. 2020 Sep 10. doi: 10.1002/jmv.26504.
    PubMed     Abstract available


  152. TAGHILOO S, Aliyali M, Abedi S, Mehravaran H, et al
    Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients; clinical and laboratory characteristics.
    J Med Virol. 2020 Sep 10. doi: 10.1002/jmv.26505.
    PubMed     Abstract available


  153. DE FLORA S, La Maestra S
    Growth and decline of the COVID-19 epidemic wave in Italy from March to June 2020.
    J Med Virol. 2020 Sep 9. doi: 10.1002/jmv.26499.
    PubMed     Abstract available


  154. KANDEEL M, Kitade Y, Fayez M, Venugopala KN, et al
    The Emerging SARS-CoV-2 Papain-like Protease: Its Relationship with Recent Coronavirus Epidemics.
    J Med Virol. 2020 Sep 9. doi: 10.1002/jmv.26497.
    PubMed     Abstract available


  155. KOW CS, Hasan SS
    Mortality of COVID-19 with preadmission metformin use in patients with diabetes: a meta-analysis.
    J Med Virol. 2020 Sep 9. doi: 10.1002/jmv.26498.
    PubMed     Abstract available


  156. YAMAMOTO S, Saito M, Nagai E, Toriuchi K, et al
    Seroconversion against SARS-CoV-2 occurred after the recovery in patients with COVID-19.
    J Med Virol. 2020 Sep 8. doi: 10.1002/jmv.26495.
    PubMed     Abstract available


  157. ARAFKAS M, Khosrawipour T, Kocbach P, Zielinski K, et al
    Current meta-analysis does not support the possibility of COVID-19 reinfections.
    J Med Virol. 2020 Sep 8. doi: 10.1002/jmv.26496.
    PubMed     Abstract available


  158. KAWAMURA Y, Higashimoto Y, Miura H, Ihira M, et al
    Immune response against SARS-CoV-2 in pediatric patients including young infants.
    J Med Virol. 2020 Sep 8. doi: 10.1002/jmv.26493.
    PubMed     Abstract available


  159. LIU X, Liu Y, Wang L, Hu L, et al
    Analysis of the prophylactic effect of thymosin drugs on COVID-19 for 435 medical staff: A hospital-based retrospective study.
    J Med Virol. 2020 Sep 8. doi: 10.1002/jmv.26492.
    PubMed     Abstract available


  160. GRECO G, Ripamonti D, Binda F, Fabretti F, et al
    Potential role of subcutaneous tocilizumab injections in patients with COVID-19 associated pneumonia.
    J Med Virol. 2020 Sep 8. doi: 10.1002/jmv.26494.
    PubMed     Abstract available


  161. LI Y, Ji D, Cai W, Hu Y, et al
    Clinical characteristics, cause analysis and infectivity of COVID-19 nucleic acid re-positive patients: A literature review.
    J Med Virol. 2020 Sep 5. doi: 10.1002/jmv.26491.
    PubMed     Abstract available


  162. BIGUENET A, Bouiller K, Marty-Quinternet S, Brunel AS, et al
    SARS-CoV-2 respiratory viral loads and association with clinical and biological features.
    J Med Virol. 2020 Sep 5. doi: 10.1002/jmv.26489.
    PubMed     Abstract available


  163. ABBAS HM, Nassir KF, Al Khames Aga QA, Al-Gharawi AA, et al
    Presenting characteristics, smoking versus diabetes and outcome among patients hospitalized with COVID-19.
    J Med Virol. 2020 Sep 4. doi: 10.1002/jmv.26487.
    PubMed     Abstract available


  164. DAUBY N, Van Praet S, Vanhomwegen C, Veliziotis I, et al
    Tolerability of Favipiravir therapy in critically-ill patients with COVID-19: a report of 4 cases.
    J Med Virol. 2020 Sep 4. doi: 10.1002/jmv.26488.
    PubMed     Abstract available


  165. GIRIJA A S S
    Fox3(+) CD25(+) CD4(+) T regulatory cells (Tregs) may transform the n-CoV's final destiny to CNS!
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26482.
    PubMed     Abstract available


  166. TAN JY, Sim XYJ, Liang En W, Chua YY, et al
    A comparative study on the clinical features of COVID-19 with non-SARS-CoV-2 respiratory viral infections.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26486.
    PubMed     Abstract available


  167. ESTOFOLETE CF, Machado LF, Zini N, Luckemeyer GD, et al
    Fatal stroke as presentation of SARS-CoV-2 and dengue virus coinfection.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26476.
    PubMed     Abstract available


  168. CAPETTI AF, Borgonovo F, Morena V, Lupo A, et al
    Short-term inhibition of SARS-CoV-2 by hydrogen peroxide in persistent nasopharyngeal carriers.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26485.
    PubMed     Abstract available


  169. CLIFT AK
    Deriving 'definitive' results in observational COVID-19 research: a problematic endeavour.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26481.
    PubMed     Abstract available


  170. KHAN AW, Ullah I, Khan KS
    Ischemic stroke leading to bilateral vision loss in COVID-19 patient- A rare case report.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26484.
    PubMed     Abstract available


  171. SARKAR S, Khanna P, Soni KD
    Are the steroids a blanket solution for COVID-19? a systematic review and meta-analysis.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26483.
    PubMed     Abstract available


  172. SEYRAN M, Pizzol D, Adadi P, El-Aziz TMA, et al
    Questions concerning the proximal origin of SARS-CoV-2.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26478.
    PubMed     Abstract available


  173. ANASTASIOU OE, Theodoropoulos F, Taube C, Fiedler M, et al
    Common respiratory viral infections: Bilateral vs unilateral bronchoalveolar lavage vs endotracheal aspiration.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26477.
    PubMed     Abstract available


  174. HENRY BM, Benoit J, Berger B, Pulvino C, et al
    Coronavirus Disease 2019 (COVID-19) is Associated with Low Circulating Plasma Levels of Angiotensin 1 and Angiotensin 1,7.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26479.
    PubMed     Abstract available


  175. GARG J, Singh V, Pandey P, Verma A, et al
    Evaluation of sample pooling for diagnosis of COVID-19 by Real time PCR- A resource saving combat strategy.
    J Med Virol. 2020 Sep 1. doi: 10.1002/jmv.26475.
    PubMed     Abstract available


    August 2020
  176. OZGER HS, Dizbay M, Corbacioglu SK, Aysert P, et al
    The prognostic role of neopterin in COVID-19 patients.
    J Med Virol. 2020 Aug 29. doi: 10.1002/jmv.26472.
    PubMed     Abstract available


  177. OKOH AK, Bishburg E, Grinberg S, Nagarakanti S, et al
    Tocilizumab use in COVID -19 associated pneumonia.
    J Med Virol. 2020 Aug 29. doi: 10.1002/jmv.26471.
    PubMed     Abstract available


  178. ERDEN A, Ozdemir B, Karakas O, Mutlu NM, et al
    Evaluation of seventeen patients with COVID-19 pneumonia treated with anakinra according to HScore, SOFA, MuLBSTA and Brescia-COVID respiratory severity scale (BCRSS) scoring systems.
    J Med Virol. 2020 Aug 29. doi: 10.1002/jmv.26473.
    PubMed     Abstract available


  179. ZHANG J, Ding D, Huang X, Zhang J, et al
    Differentiation of COVID-19 from seasonal influenza: a multicenter comparative study.
    J Med Virol. 2020 Aug 28. doi: 10.1002/jmv.26469.
    PubMed     Abstract available


  180. SAGNELLI C, Celia B, Monari C, Cirillo S, et al
    Management of SARS-CoV-2 Pneumonia.
    J Med Virol. 2020 Aug 28. doi: 10.1002/jmv.26470.
    PubMed     Abstract available


  181. CHRISTOU MS, Mohamed MS, Tsigarides J
    Tocilizumab - A beacon of hope in the management of severe COVID-19?
    J Med Virol. 2020 Aug 28. doi: 10.1002/jmv.26466.
    PubMed     Abstract available


  182. GARG P, Arora U, Kumar A, Wig N, et al
    The "Post-COVID" Syndrome: How Deep is the Damage?
    J Med Virol. 2020 Aug 27. doi: 10.1002/jmv.26465.
    PubMed     Abstract available


  183. BUTT MH, Ahmad A, Misbah S, Mallhi TH, et al
    Dengue Fever and COVID-19 Co-Infection; A Threat to Public Health for Co-epidemic in Pakistan.
    J Med Virol. 2020 Aug 27. doi: 10.1002/jmv.26464.
    PubMed     Abstract available


  184. AMIN D, McKitish K, Shah PS
    Association of Mortality and Recent M. Pneumoniae Infection in COVID-19 Patients.
    J Med Virol. 2020 Aug 27. doi: 10.1002/jmv.26467.
    PubMed     Abstract available


  185. SERGI CM, Chiu B
    Targeting NLRP3 Inflammasome in an Animal Model for SARS-CoV-2.
    J Med Virol. 2020 Aug 25. doi: 10.1002/jmv.26461.
    PubMed    


  186. PASOMSUB E, Watcharananan SP, Watthanachockchai T, Rakmanee K, et al
    Saliva sample pooling for the detection of SARS-CoV-2.
    J Med Virol. 2020 Aug 25. doi: 10.1002/jmv.26460.
    PubMed     Abstract available


  187. REDDY RK, Charles WN, Sklavounos A, Seed PT, et al
    Impact of smoking on COVID-19 severity.
    J Med Virol. 2020 Aug 25. doi: 10.1002/jmv.26456.
    PubMed    


  188. MASSAROTTI C, Adriano M, Cagnacci A, Gorlero F, et al
    Asymptomatic SARS-CoV-2 infections in pregnant patients in an Italian city during complete lockdown.
    J Med Virol. 2020 Aug 25. doi: 10.1002/jmv.26458.
    PubMed     Abstract available


  189. MITTAL S, Madan K, Mohan A, Tiwari P, et al
    Diabetes in COVID-19: Steroid effect.
    J Med Virol. 2020 Aug 25. doi: 10.1002/jmv.26457.
    PubMed    


  190. TOMASONI D, Bai F, Castoldi R, Barbanotti D, et al
    Anxiety and depression symptoms after virological clearance of COVID-19: a cross-sectional study in Milan, Italy.
    J Med Virol. 2020 Aug 25. doi: 10.1002/jmv.26459.
    PubMed     Abstract available


  191. CHEN JM
    Live unattenuated vaccines for controlling viral diseases including COVID-19.
    J Med Virol. 2020 Aug 24. doi: 10.1002/jmv.26453.
    PubMed     Abstract available


  192. DE SOUSA FACG, Paradella TC
    Considerations on oral manifestations of COVID-19.
    J Med Virol. 2020 Aug 22. doi: 10.1002/jmv.26451.
    PubMed     Abstract available


  193. ISLAM MZ, E-Zahan MK, Al-Bari MAA
    Convergence between global BCG vaccination and COVID-19 pandemic.
    J Med Virol. 2020 Aug 22. doi: 10.1002/jmv.26450.
    PubMed     Abstract available


  194. MICHELI V, Rimoldi SG, Romeri F, Comandatore F, et al
    Geographical reconstruction of the SARS-CoV-2 outbreak in Lombardy (Italy) during the early phase.
    J Med Virol. 2020 Aug 20. doi: 10.1002/jmv.26447.
    PubMed     Abstract available


  195. KHOURY NC, Russi TJ
    A Case of Gastrointestinal-Predominant COVID-19 Demonstrates Value of Stool PCR Test.
    J Med Virol. 2020 Aug 20. doi: 10.1002/jmv.26448.
    PubMed     Abstract available


  196. TAO Z, Xu J, Chen W, Yang Z, et al
    Anaemia is associated with severe illness in COVID-19: a retrospective cohort study.
    J Med Virol. 2020 Aug 19. doi: 10.1002/jmv.26444.
    PubMed     Abstract available


  197. BOUAYED J, Bohn T
    Behavioural manipulation - key to the successful global spread of the new Coronavirus SARS-Cov-2?
    J Med Virol. 2020 Aug 19. doi: 10.1002/jmv.26446.
    PubMed     Abstract available


  198. JIANG Y, Chen D, Cai D, Yi Y, et al
    Effectiveness of remdesivir for the treatment of hospitalized Covid-19 persons: a network meta-analysis.
    J Med Virol. 2020 Aug 19. doi: 10.1002/jmv.26443.
    PubMed     Abstract available


  199. XU R, Huang J, Duan C, Liao Q, et al
    Low prevalence of antibodies against SARS-CoV-2 among voluntary blood donors in Guangzhou, China.
    J Med Virol. 2020 Aug 19. doi: 10.1002/jmv.26445.
    PubMed     Abstract available


  200. ELSAWAH HK, Elsokary MA, Elrazzaz MG, ElShafey AH, et al
    Hydroxychloroquine for treatment of non-severe COVID-19 patients; systematic review and meta-analysis of controlled clinical trials.
    J Med Virol. 2020 Aug 18. doi: 10.1002/jmv.26442.
    PubMed     Abstract available


  201. GONCALVES MENDES NETO A, Lo KB, Wattoo A, Salacup G, et al
    Bacterial Infections and Patterns of Antibiotic Use in Patients with COVID-19.
    J Med Virol. 2020 Aug 18. doi: 10.1002/jmv.26441.
    PubMed     Abstract available


  202. JOVANI V, Pascual E, Vela P, Andres M, et al
    Acute arthritis following SARS-CoV-2 infection.
    J Med Virol. 2020 Aug 18. doi: 10.1002/jmv.26440.
    PubMed     Abstract available


  203. XUE M, Zhang T, Hu H, Huang Z, et al
    Predictive effects of IgA and IgG combination to assess pulmonary exudation progression in COVID-19 patients.
    J Med Virol. 2020 Aug 17. doi: 10.1002/jmv.26437.
    PubMed     Abstract available


  204. SOLEIMANI R, Khourssaji M, Gruson D, Rodriguez-Villalobos H, et al
    Clinical usefulness of fully automated chemiluminescent immunoassay for quantitative antibody measurements in COVID-19 patients.
    J Med Virol. 2020 Aug 14. doi: 10.1002/jmv.26430.
    PubMed     Abstract available


  205. D'ALESSANDRO M, Cameli P, Bergantini L, Franchi F, et al
    Serum concentrations of Krebs von den Lungen-6 in different COVID-19 phenotypes.
    J Med Virol. 2020 Aug 14. doi: 10.1002/jmv.26431.
    PubMed     Abstract available


  206. ALONSO FOM, Sabino BD, Guimaraes MAAM, Varella RB, et al
    Recurrence of SARS-CoV-2 infection with a more severe case after mild COVID-19, reversion of RT-qPCR for positive and late antibody response: case report.
    J Med Virol. 2020 Aug 14. doi: 10.1002/jmv.26432.
    PubMed     Abstract available


  207. BASIRJAFARI S, Rafiee M, Shahhosseini B, Mohammadi M, et al
    Association of Pediatric COVID-19 and Subarachnoid Hemorrhage.
    J Med Virol. 2020 Aug 14. doi: 10.1002/jmv.26434.
    PubMed     Abstract available


  208. CHOE SA, An HS, Choe YJ
    No Temporal Association between Human Coronavirus and Kawasaki Disease: National Data from South Korea.
    J Med Virol. 2020 Aug 14. doi: 10.1002/jmv.26435.
    PubMed     Abstract available


  209. BARTILOTTI-MATOS F, Davies P
    Pearls and Pitfalls: two contrasting HIV diagnoses in the COVID-19 era and the case for screening.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26428.
    PubMed     Abstract available


  210. SAM IC, Chong YM, Tan CW, Chan YF, et al
    Low post-pandemic wave SARS-CoV-2 seroprevalence in Kuala Lumpur and Selangor, Malaysia.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26426.
    PubMed     Abstract available


  211. TAKAGI H
    Risk and protective factors of SARS-CoV-2 infection.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26427.
    PubMed     Abstract available


  212. INFANTINO M, Manfredi M, Grossi V, Lari B, et al
    Closing the Serological Gap in the Diagnostic Testing for COVID-19: The Value of Anti-SARS-CoV-2 IgA Antibodies.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26422.
    PubMed     Abstract available


  213. LI J, Huang DQ, Zou B, Yang H, et al
    Epidemiology of COVID-19: A Systematic Review and Meta-analysis of Clinical Characteristics, Risk factors and Outcomes.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26424.
    PubMed     Abstract available


  214. FIORE JR, Centra M, De Carlo A, Granato T, et al
    Results from a survey in healthy blood donors in South Eastern Italy indicate that we are far away from herd immunity to SARS-CoV-2.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26425.
    PubMed     Abstract available


  215. PETTIT NN, Nguyen CT, Mutlu GM, Wu D, et al
    Late Onset Infectious Complications and Safety of Tocilizumab in the Management of COVID-19.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26429.
    PubMed     Abstract available


  216. BURGOS-BLASCO B, Guemes-Villahoz N, Vidal-Villegas B, Donate-Lopez J, et al
    Evaluation of retinotoxicity of COVID-19 treatment: hydroxychloroquine and lopinavir/ritonavir.
    J Med Virol. 2020 Aug 12. doi: 10.1002/jmv.26420.
    PubMed     Abstract available


  217. BANERJEE S, Seal S, Dey R, Mondal KK, et al
    Mutational spectra of SARS-CoV-2 orf1ab polyprotein and signature mutations in the United States of America.
    J Med Virol. 2020 Aug 11. doi: 10.1002/jmv.26417.
    PubMed     Abstract available


  218. SHU L, Wang X, Li M, Chen X, et al
    Clinical Characteristics of Moderate COVID-19 Patients Aggravation in Wuhan Stadium Cabin Hospital: A 571 Cases of Retrospective Cohort Study.
    J Med Virol. 2020 Aug 11. doi: 10.1002/jmv.26414.
    PubMed     Abstract available


  219. PATEL RH, Acharya A, Mohan M, Byrareddy SN, et al
    COVID-19 and AIDS: outcomes from the co-existence of two global pandemics and the importance of chronic antiretroviral therapy.
    J Med Virol. 2020 Aug 11. doi: 10.1002/jmv.26416.
    PubMed     Abstract available


  220. ONCUL H, Oncul FY, Alakus MF, Caglayan M, et al
    Ocular findings in patients with coronavirus disease 2019 (COVID-19) in an outbreak hospital.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26412.
    PubMed     Abstract available


  221. YIGENOGLU TN, Ata N, Altuntas F, Basci S, et al
    The Outcome of COVID-19 in Patients with Hematological Malignancy.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26404.
    PubMed     Abstract available


  222. SARKAR S, Soni KD, Khanna P
    Convalescent plasma a clutch at straws in COVID-19 management! A systematic review and meta-analysis.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26408.
    PubMed     Abstract available


  223. LU W, Liu X, Wang T, Liu F, et al
    Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID-19 Patients.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26406.
    PubMed     Abstract available


  224. KHINDA J, Janjua NZ, Cheng S, van den Heuvel ER, et al
    Association between markers of immune response at hospital admission and COVID-19 disease severity and mortality: A meta-analysis and meta-regression.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26411.
    PubMed     Abstract available


  225. MIYAZAWA D, Kaneko G
    Clinical trials of inhaled beclomethasone and mometasone for COVID-19 should be conducted.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26413.
    PubMed     Abstract available


  226. SAHU KK, Borogovac A, Cerny J
    COVID-19 related immune hemolysis and thrombocytopenia.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26402.
    PubMed     Abstract available


  227. GIACOMELLI A, Pagani G, Ridolfo AL, Bit LO, et al
    Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: a retrospective cohort study.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26407.
    PubMed     Abstract available


  228. BATUR LK, Hekim N
    The role of DBP gene polymorphisms in the prevalence of new coronavirus disease 2019 infection and mortality rate.
    J Med Virol. 2020 Aug 8. doi: 10.1002/jmv.26409.
    PubMed     Abstract available


  229. HARTNACK S, Eusebi P, Kostoulas P
    Bayesian latent class models to estimate diagnostic test accuracies of COVID-19 tests.
    J Med Virol. 2020 Aug 8. doi: 10.1002/jmv.26405.
    PubMed     Abstract available


  230. ALPAYDIN AO, Gezer NS, Simsek GO, Tertemiz KC, et al
    Clinical and Radiological Diagnosis of Non-SARS-CoV-2 Viruses in the Era of Covid-19 Pandemic.
    J Med Virol. 2020 Aug 8. doi: 10.1002/jmv.26410.
    PubMed     Abstract available


  231. MALTEZOU HC, Vorou R, Papadima K, Kossyvakis A, et al
    Transmission dynamics of SARS-CoV-2 within families with children in Greece: a study of 23 clusters.
    J Med Virol. 2020 Aug 7. doi: 10.1002/jmv.26394.
    PubMed     Abstract available


  232. KO M, Jeon S, Ryu WS, Kim S, et al
    Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells.
    J Med Virol. 2020 Aug 7. doi: 10.1002/jmv.26397.
    PubMed     Abstract available


  233. HASHEMI SA, Safamanesh S, Zadeh-Moghaddam HG, Ghafouri M, et al
    Report of death in children with SARS-CoV-2 and Human metapneumovirus (hMPV) co-infection: is hMPV the trigger?
    J Med Virol. 2020 Aug 7. doi: 10.1002/jmv.26401.
    PubMed     Abstract available


  234. FINSTERER J, Scorza FA
    SARS-CoV-2 myopathy.
    J Med Virol. 2020 Aug 6. doi: 10.1002/jmv.26399.
    PubMed     Abstract available


  235. VALDIVIA A, Torres I, Huntley D, Alcaraz MJ, et al
    Caveats in interpreting SARS-CoV-2 IgM positive/IgG negative antibody profile in asymptomatic health care workers.
    J Med Virol. 2020 Aug 6. doi: 10.1002/jmv.26400.
    PubMed     Abstract available


  236. RAMIREZ JD, Florez C, Munoz M, Hernandez C, et al
    The arrival and spread of SARS-CoV2 in Colombia.
    J Med Virol. 2020 Aug 6. doi: 10.1002/jmv.26393.
    PubMed     Abstract available


  237. FAQIHI F, Alharthy A, Memish ZA, Karakitsos D, et al
    Comment on Hu et al: The cytokine storm and COVID-19.
    J Med Virol. 2020 Aug 6. doi: 10.1002/jmv.26396.
    PubMed     Abstract available


  238. CUI X, Zhao Z, Zhang T, Guo W, et al
    A systematic review and meta-analysis of children with Coronavirus Disease 2019 (COVID-19).
    J Med Virol. 2020 Aug 6. doi: 10.1002/jmv.26398.
    PubMed     Abstract available


  239. BUTT MH, Ahmad A, Misbah S, Mallhi TH, et al
    Crimean-Congo Haemorrhagic Fever and Eid-Ul-Adha; A potential threat during the COVID-19 Pandemic.
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26388.
    PubMed     Abstract available


  240. HSU AL, Guan M, Johannesen E, Stephens AJ, et al
    Placental SARS-CoV-2 in a Pregnant Woman with Mild COVID-19 Disease.
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26386.
    PubMed     Abstract available


  241. CHEN J, Pan Y, Li G, Xu W, et al
    Distinguishing between COVID-19 and influenza during the early stages by measurement of peripheral blood parameters.
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26384.
    PubMed     Abstract available


  242. CAMPANA P, Flocco V, Aruta F, Cacciatore F, et al
    Can Aldosterone increase Interleukin-6 levels in Covid-19 Pneumonia?
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26382.
    PubMed     Abstract available


  243. REDDY RK, Charles WN, Sklavounos A, Dutt A, et al
    The effect of smoking on COVID-19 severity: a systematic review and meta-analysis.
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26389.
    PubMed     Abstract available


  244. COLLINS GS, Wilkinson J
    Statistical issues in the development a COVID-19 prediction models.
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26390.
    PubMed     Abstract available


  245. PATRA R, Chandra Das N, Mukherjee S
    Targeting human TLRs to combat COVID-19: A solution?
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26387.
    PubMed     Abstract available


  246. MATTIUZZI C, Lippi G
    Serum prealbumin values predict the severity of coronavirus disease 2019 (COVID-19).
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26385.
    PubMed     Abstract available


  247. GOES LGB, Zerbinati RM, Tateno AF, de Souza AV, et al
    Typical epidemiology of respiratory virus infections in a Brazilian slum.
    J Med Virol. 2020;92:1316-1321.
    PubMed     Abstract available


    July 2020
  248. ZHAO T, Xuan K, Uy JP, Sun C, et al
    In the shadow of COVID-19: HIV-infected individuals need more attention.
    J Med Virol. 2020 Jul 31. doi: 10.1002/jmv.26378.
    PubMed     Abstract available


  249. TATIANA S
    Could an acute respiratory distress syndrome (ARDS) in COVID-19 infected patients be calmed down simply by iron withdrawal from lung tissues?
    J Med Virol. 2020 Jul 30. doi: 10.1002/jmv.26372.
    PubMed     Abstract available


  250. BANSAL N, Bansal Y, Ralta A
    Thrombocytopenia in COVID-19 patients in Himachal Pradesh (India) and the absence of dengue false positive tests: Insights for patient management.
    J Med Virol. 2020 Jul 30. doi: 10.1002/jmv.26373.
    PubMed     Abstract available


  251. HALPIN SJ, McIvor C, Whyatt G, Adams A, et al
    Post-discharge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation.
    J Med Virol. 2020 Jul 30. doi: 10.1002/jmv.26368.
    PubMed     Abstract available


  252. KHAN KS, Torpiano G, McLellan M, Mahmud S, et al
    The impact of socioeconomic status on 30-day mortality in hospitalised patients with COVID-19 infection.
    J Med Virol. 2020 Jul 30. doi: 10.1002/jmv.26371.
    PubMed     Abstract available


  253. TALMY T, Tsur A, Shabtay O
    Duration of SARS-CoV-2 Detection in Israel Defense Forces Soldiers with Mild COVID-19.
    J Med Virol. 2020 Jul 30. doi: 10.1002/jmv.26374.
    PubMed     Abstract available


  254. SUWANWONGSE K, Shabarek N
    Variation in mortality of HIV/SARS-CoV-2 co-infected patients in the Bronx, New York City.
    J Med Virol. 2020 Jul 29. doi: 10.1002/jmv.26370.
    PubMed     Abstract available


  255. ZHENG X, Chen J, Deng L, Fang Z, et al
    Risk factors for the COVID-19 severity and its correlation with viral shedding: a retrospective cohort study.
    J Med Virol. 2020 Jul 29. doi: 10.1002/jmv.26367.
    PubMed     Abstract available


  256. KANEKO S, Nukui Y, Arashiro T, Aiso Y, et al
    Clinical validation of an immunochromatographic SARS-Cov-2 IgM/IgG antibody assay with Japanese cohort.
    J Med Virol. 2020 Jul 28. doi: 10.1002/jmv.26363.
    PubMed     Abstract available


  257. HASHEMI SA, Safamanesh S, Ghasemzadeh-Moghaddam H, Ghafouri M, et al
    High prevalence of SARS-CoV-2 and influenza A virus (H1N1) co-infection in dead patients in Northeastern Iran.
    J Med Virol. 2020 Jul 28. doi: 10.1002/jmv.26364.
    PubMed     Abstract available


  258. MAEDA T, Obata R, Rizk DO D, Kuno T, et al
    The Association of Interleukin-6 value, Interleukin inhibitors and Outcomes of Patients with COVID-19 in New York City.
    J Med Virol. 2020 Jul 28. doi: 10.1002/jmv.26365.
    PubMed     Abstract available


  259. MUNSHI R, Hussein MH, Toraih EA, Elshazli RM, et al
    Vitamin D insufficiency as a potential culprit in critical COVID-19 patients.
    J Med Virol. 2020 Jul 27. doi: 10.1002/jmv.26360.
    PubMed     Abstract available


  260. POTERICO JA, Mestanza O
    Response to Comment on "Genetic Variants and Source of Introduction of SARS-CoV-2 in South America".
    J Med Virol. 2020 Jul 27. doi: 10.1002/jmv.26359.
    PubMed     Abstract available


  261. PAIVA KJ, Grisson RD, Chan PA, Huard RC, et al
    Validation and Performance Comparison of Three SARS-CoV-2 Antibody Assays.
    J Med Virol. 2020 Jul 25. doi: 10.1002/jmv.26341.
    PubMed     Abstract available


  262. ZHANG C, Lin L, Tang D, Liu F, et al
    Antibody responses to SARS-CoV-2 in healthy individuals returning to Shenzhen.
    J Med Virol. 2020 Jul 25. doi: 10.1002/jmv.26355.
    PubMed     Abstract available


  263. HARMOUCH F, Shah K, Hippen J, Kumar A, et al
    Is it all in the heart? Myocardial injury as major predictor of mortality among hospitalized COVID-19 patients.
    J Med Virol. 2020 Jul 25. doi: 10.1002/jmv.26347.
    PubMed     Abstract available


  264. BARILLARI MR, Bastiani L, Lechien JR, Mannelli G, et al
    A Structural Equation Model to Examine the Clinical Features of Mild-to-Moderate Covid-19: A Multicenter Italian Study.
    J Med Virol. 2020 Jul 25. doi: 10.1002/jmv.26354.
    PubMed     Abstract available


  265. LIN J, Yan H, Chen H, He C, et al
    COVID-19 and Coagulation Dysfunction in Adults: A Systematic Review and Meta-analysis.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26346.
    PubMed     Abstract available


  266. ZHOU W, Xu X, Chang Z, Wang H, et al
    The dynamic changes of serum IgM and IgG against SARS-CoV-2 in patients with COVID-19.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26353.
    PubMed     Abstract available


  267. VALDIVIA A, Torres I, Huntley D, Alcaraz MJ, et al
    Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26344.
    PubMed     Abstract available


  268. BARRERA-LOPEZ P, Perez-Riveros ED, Moreno-Montoya J, Ballesteros SM, et al
    Co-infection of other respiratory pathogens and HIV in COVID-19 patients: is there a pattern?
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26331.
    PubMed     Abstract available


  269. KHAN KS, Ullah I
    SARS-CoV-2 Causes Kawasaki like Disease in children; Cases reported in Pakistan.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26340.
    PubMed     Abstract available


  270. MAGGIOLO F, Zoboli F, Arosio M, Valenti D, et al
    SARS-CoV-2 infection in persons living with HIV: a single center prospective cohort.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26352.
    PubMed     Abstract available


  271. DIN M, Asghar M, Ali M
    COVID-19 and dengue coepidemics: A double trouble for overburdened health systems in developing countries.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26348.
    PubMed    


  272. BRITO-AZEVEDO A, Pinto EC, de Cata Preta Correa GA, Bouskela E, et al
    SARS-Cov-2 infection causes pulmonary shunt by vasodilatation.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26342.
    PubMed     Abstract available


  273. ZHU J, Pang J, Ji P, Zhong Z, et al
    Coagulation dysfunction is associated with severity of COVID-19: a meta-analysis.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26336.
    PubMed     Abstract available


  274. SUWANWONGSE K, Shabarek N
    Newly diagnosed diabetes mellitus, DKA and COVID-19: causality or coincidence? - A report of 3 cases.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26339.
    PubMed     Abstract available


  275. BWIRE GM, Majigo MV, Njiro BJ, Mawazo A, et al
    Detection profile of SARS-CoV-2 using RT-PCR in different types of clinical specimens: a systematic review and meta-analysis.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26349.
    PubMed     Abstract available


  276. VAN GERWEN M, Alsen M, Little C, Barlow J, et al
    Risk factors and outcomes of COVID-19 in New York City; a retrospective cohort study.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26337.
    PubMed     Abstract available


  277. COMAS C, Carreras E
    COVID-19 and pregnancy: an opportunity to correct an historic gender bias.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26350.
    PubMed     Abstract available


  278. VENKATESULU BP, Thoguluva Chandrasekar V, Girdhar P, Pragathee V, et al
    The mechanistic rationale of drugs, Primary endpoints, Geographical distribution of clinical trials against Severe acute respiratory syndrome-related coronavirus-2: A Systematic Review.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26338.
    PubMed     Abstract available


  279. ADAMS NM, Leelawong M, Benton A, Quinn C, et al
    COVID-19 diagnostics for resource-limited settings: Evaluation of "unextracted" qRT-PCR.
    J Med Virol. 2020 Jul 23. doi: 10.1002/jmv.26328.
    PubMed     Abstract available


  280. ZHENG Y, Yan M, Wang L, Luan L, et al
    Analysis of the application value of serum antibody detection for staging of COVID-19 infection.
    J Med Virol. 2020 Jul 23. doi: 10.1002/jmv.26330.
    PubMed     Abstract available


  281. WANG P
    Recurrent presence of SARS-CoV-2 RNA in a 33-year-old man.
    J Med Virol. 2020 Jul 22. doi: 10.1002/jmv.26334.
    PubMed     Abstract available


  282. TURRIZIANI O, Sciandra I, Mazzuti L, Di Carlo D, et al
    SARS-CoV-2 diagnostics in the virology laboratory of a University Hospital in Rome during the lockdown period.
    J Med Virol. 2020 Jul 22. doi: 10.1002/jmv.26332.
    PubMed     Abstract available


  283. TAKAGI H, Kuno T, Yokoyama Y, Ueyama H, et al
    Meta-regression of COVID-19 prevalence/fatality on socioeconomic characteristics of data from top 50 U.S. large cities.
    J Med Virol. 2020 Jul 22. doi: 10.1002/jmv.26335.
    PubMed     Abstract available


  284. NABIL B, Sabrina B, Abdelhakim B
    Transmission route and introduction of Pandemic SARS-CoV-2 between China, Italy and Spain.
    J Med Virol. 2020 Jul 22. doi: 10.1002/jmv.26333.
    PubMed     Abstract available


  285. KANWUGU ON, Adadi P
    HIV/SARS-CoV-2 coinfection: a global perspective.
    J Med Virol. 2020 Jul 21. doi: 10.1002/jmv.26321.
    PubMed     Abstract available


  286. DENG K, Li H, Ma X, Yu B, et al
    Analysis of the positive rate of 4254 cases of COVID-19 nucleic acid tests in Different Sites in Wuhan, China.
    J Med Virol. 2020 Jul 21. doi: 10.1002/jmv.26323.
    PubMed     Abstract available


  287. DIOTALLEVI F, Campanati A, Radi G, Luchetti MM, et al
    Hydroxychloroquine, Dermatology and SARS-CoV-2: Updating an Old Association.
    J Med Virol. 2020 Jul 21. doi: 10.1002/jmv.26322.
    PubMed     Abstract available


  288. TORRE-FUENTES L, Matias-Guiu J, Hernandez-Lorenzo L, Montero-Escribano P, et al
    ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain.
    J Med Virol. 2020 Jul 21. doi: 10.1002/jmv.26319.
    PubMed     Abstract available


  289. HE J, Guo Y, Mao R, Zhang J, et al
    Proportion of asymptomatic coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis.
    J Med Virol. 2020 Jul 21. doi: 10.1002/jmv.26326.
    PubMed     Abstract available


  290. HOANG T, Thi Anh TT
    Ambient Air Pollution, Meteorology, and COVID-19 Infection in Korea.
    J Med Virol. 2020 Jul 21. doi: 10.1002/jmv.26325.
    PubMed     Abstract available


  291. WANG Y, Wang L, Cao H, Liu C, et al
    SARS-CoV-2 S1 is superior to the RBD as a COVID-19 subunit vaccine antigen.
    J Med Virol. 2020 Jul 21. doi: 10.1002/jmv.26320.
    PubMed     Abstract available


  292. GEORGE S, Ansari MS, Kalliath A, Khan MJ, et al
    COVID-19 in children in Brunei Darussalam: Higher incidence but mild manifestations.
    J Med Virol. 2020 Jul 20. doi: 10.1002/jmv.26310.
    PubMed     Abstract available


  293. GAO Y, Liu M, Chen Y, Shi S, et al
    Association between tuberculosis and COVID-19 severity and mortality: a rapid systematic review and meta-analysis.
    J Med Virol. 2020 Jul 20. doi: 10.1002/jmv.26311.
    PubMed     Abstract available


  294. LIU X, Liu Y, Chen K, Yan S, et al
    Efficacy of ACEIs/ARBs versus CCBs on the progression of COVID-19 patients with hypertension in Wuhan: A hospital-based retrospective cohort study.
    J Med Virol. 2020 Jul 20. doi: 10.1002/jmv.26315.
    PubMed     Abstract available


  295. ZARIFIAN A, Bidary MZ, Arekhi S, Rafiee M, et al
    Gastrointestinal and hepatic abnormalities in patients with confirmed COVID-19: a systematic review and meta-analysis.
    J Med Virol. 2020 Jul 18. doi: 10.1002/jmv.26314.
    PubMed     Abstract available


  296. DA SILVA PEDROSA M
    Are salivary glands the key players in spreading COVID-19 asymptomatic infection?
    J Med Virol. 2020 Jul 18. doi: 10.1002/jmv.26316.
    PubMed     Abstract available


  297. ZAIDI SZA, Zaidi FZ, AlShehry N, Zaidi ARZ, et al
    Aging and Therapy-Related Hypogammaglobulinemia causing Pneumonia: An Overlooked Curable Entity in the Chaotic COVID-19 Pandemic.
    J Med Virol. 2020 Jul 18. doi: 10.1002/jmv.26318.
    PubMed    


  298. MONNERET G, Benlyamani I, Gossez M, Martin JB, et al
    COVID-19: what type of cytokine storm are we dealing with?
    J Med Virol. 2020 Jul 18. doi: 10.1002/jmv.26317.
    PubMed     Abstract available


  299. CHEN JM
    SARS-CoV-2 replicating in non-primate mammalian cells probably have critical advantages for COVID-19 vaccines due to anti-Gal antibodies: A minireview and proposals.
    J Med Virol. 2020 Jul 18. doi: 10.1002/jmv.26312.
    PubMed     Abstract available


  300. FERNANDEZ-RUIZ M, Lopez-Medrano F, Asin MAP, de la Calle GM, et al
    Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: a single-center cohort study.
    J Med Virol. 2020 Jul 16. doi: 10.1002/jmv.26308.
    PubMed     Abstract available


  301. GAYAM V, Chobufo MD, Merghani MA, Lamichanne S, et al
    Clinical characteristics and predictors of mortality in African-Americans with COVID-19 from an inner-city community teaching hospital in New York.
    J Med Virol. 2020 Jul 16. doi: 10.1002/jmv.26306.
    PubMed     Abstract available


  302. POUGA L
    Encephalitic syndrome and anosmia in COVID-19: do these clinical presentations really reflect SARS-CoV-2 neurotropism? A theory based on the review of 25 COVID-19 cases.
    J Med Virol. 2020 Jul 16. doi: 10.1002/jmv.26309.
    PubMed     Abstract available


  303. LIN W, Xie Z, Li Y, Li L, et al
    Association between detectable SARS-COV-2 RNA in anal swabs and disease severity in patients with Coronavirus Disease 2019.
    J Med Virol. 2020 Jul 16. doi: 10.1002/jmv.26307.
    PubMed     Abstract available


  304. TRE-HARDY M, Wilmet A, Beukinga I, Favresse J, et al
    Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA and IgM antibodies.
    J Med Virol. 2020 Jul 15. doi: 10.1002/jmv.26303.
    PubMed     Abstract available


  305. CHANDRASEKAR VT, Venkatesalu B, Patel HK, Spadaccini M, et al
    Systematic Review and Meta-analysis of Effectiveness of Treatment Options Against SARS-CoV-2 infection.
    J Med Virol. 2020 Jul 15. doi: 10.1002/jmv.26302.
    PubMed     Abstract available


  306. MANGANOTTI P, Bellavita G, D'Acunto L, Tommasini V, et al
    Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain Barre syndrome and polyneuritis cranialis in COVID-19 patients: a case series.
    J Med Virol. 2020 Jul 14. doi: 10.1002/jmv.26289.
    PubMed     Abstract available


  307. OK F, Erdogan O, Durmus E, Carkci S, et al
    Predictive Values of Blood Urea Nitrogen/Creatinine Ratio and Other Routine Blood Parameters on Disease Severity and Survival of COVID-19 Patients.
    J Med Virol. 2020 Jul 14. doi: 10.1002/jmv.26300.
    PubMed     Abstract available


  308. COPERTINO DC JR, Duarte RRR, Powell TR, Rougvie MM, et al
    Montelukast drug activity and potential against SARS-CoV-2.
    J Med Virol. 2020 Jul 13. doi: 10.1002/jmv.26299.
    PubMed     Abstract available


  309. SARICAOGLU EM, Hasanoglu I, Guner R
    The First Reactive Arthritis Case Associated with COVID-19.
    J Med Virol. 2020 Jul 11. doi: 10.1002/jmv.26296.
    PubMed     Abstract available


  310. ZHENG KI, Feng G, Liu WY, Targher G, et al
    Extra-pulmonary complications of COVID-19: a multi-system disease?
    J Med Virol. 2020 Jul 10. doi: 10.1002/jmv.26294.
    PubMed     Abstract available


  311. HAQQI A, Khurram M, Din MSU, Aftab MN, et al
    COVID-19 and Salmonella Typhi co-epidemics in Pakistan: A real problem.
    J Med Virol. 2020 Jul 10. doi: 10.1002/jmv.26293.
    PubMed     Abstract available


  312. BURGOS-BLASCO B, Guemes-Villahoz N, Donate-Lopez J, Vidal-Villegas B, et al
    Optic nerve analysis in COVID-19 patients.
    J Med Virol. 2020 Jul 10. doi: 10.1002/jmv.26290.
    PubMed     Abstract available


  313. YU HB, Wang WJ, Tang S, Chen DX, et al
    Immune responses and pathogenesis in persistently PCR-positive patients with SARS-CoV-2 infection.
    J Med Virol. 2020 Jul 9. doi: 10.1002/jmv.26287.
    PubMed     Abstract available


  314. ANTONY SJ, Davis MA, Davis MG, Almaghlouth NK, et al
    Early use of tocilizumab in the prevention of adult respiratory failure in SARS-CoV-2 infections and the utilization of interleukin-6 levels in the management.
    J Med Virol. 2020 Jul 9. doi: 10.1002/jmv.26288.
    PubMed     Abstract available


  315. AHMED A, Tahir MJ, Siddiqi AR, Dujaili J, et al
    Possibility of Crimean-Congo Hemorrhagic Fever outbreak around Eid-ul-Adha in COVID-19 Pandemic: A way forward for Pakistan.
    J Med Virol. 2020 Jul 9. doi: 10.1002/jmv.26285.
    PubMed     Abstract available


  316. FERREIRA A, Oliveira-E-Silva A, Bettencourt P
    Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection.
    J Med Virol. 2020 Jul 9. doi: 10.1002/jmv.26286.
    PubMed     Abstract available


  317. LI TZ, Cao ZH, Chen Y, Cai MT, et al
    Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19.
    J Med Virol. 2020 Jul 9. doi: 10.1002/jmv.26280.
    PubMed     Abstract available


  318. CARALLO C, Pugliese F, Tripolino C, Lenzi L, et al
    Early-stage predictors of the acute phase duration in uncomplicated COVID-19 pneumonia.
    J Med Virol. 2020 Jul 9. doi: 10.1002/jmv.26281.
    PubMed     Abstract available


  319. BRENNER SR
    Erythropoietin Induced Hemoglobin Sub-Unit Beta may Stimulate Innate Immune RNA Virus Pattern Recognition, Suppress Reactive Oxygen Species, Reduce ACE2 Viral Doorway Opening and Neutrophil Extracellular Traps against Covid-19.
    J Med Virol. 2020 Jul 9. doi: 10.1002/jmv.26284.
    PubMed     Abstract available


  320. GOMEZ-MAYORDOMO V, Montero-Escribano P, Matias-Guiu JA, Gonzalez-Garcia N, et al
    Clinical exacerbation of SARS-CoV2 infection after fingolimod withdrawal.
    J Med Virol. 2020 Jul 9. doi: 10.1002/jmv.26279.
    PubMed     Abstract available


  321. OZARAS R, Cirpin R, Duman H, Duran A, et al
    AN OPEN CALL FOR INFLUENZA VACCINATION PENDING THE NEW WAVE OF COVID-19.
    J Med Virol. 2020 Jul 8. doi: 10.1002/jmv.26272.
    PubMed     Abstract available


  322. NUCKCHADY DC
    Hyperpyrexia and metabolic alkalosis in a COVID-19 patient.
    J Med Virol. 2020 Jul 8. doi: 10.1002/jmv.26276.
    PubMed     Abstract available


  323. WASZKIEWICZ N
    Comments on Wu et al: Possible special needs for mental online support in female and male health care workers during the COVID-19.
    J Med Virol. 2020 Jul 8. doi: 10.1002/jmv.26273.
    PubMed     Abstract available


  324. TOOMBS J, Van den Abbeele K, Democratis J, Mandal AKJ, et al
    Pneumococcal co-infection in Covid-19 patients.
    J Med Virol. 2020 Jul 8. doi: 10.1002/jmv.26278.
    PubMed     Abstract available


  325. ZHENG H, Tan J, Ma K, Meng W, et al
    Changes in RT-PCR test results and symptoms during the menstrual cycle of female individuals infected with SARS-CoV-2: report of two cases.
    J Med Virol. 2020 Jul 8. doi: 10.1002/jmv.26275.
    PubMed     Abstract available


  326. COSMA S, Borella F, Carosso A, Sciarrone A, et al
    The "scar" of a pandemic: cumulative incidence of COVID-19 during the first trimester of pregnancy.
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26267.
    PubMed     Abstract available


  327. PARK MH, Kwon DY
    A Retrospective Review of Memantine Use and COVID-19-associated Mortality from a National Database.
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26266.
    PubMed     Abstract available


  328. DIBNER J
    Fecal-Oral Transmission of COVID-19: Could Hypochlorhydria Play a Role?
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26265.
    PubMed     Abstract available


  329. MASUKUME G, Mapanga W, Grinberg S, van Zyl DS, et al
    COVID-19 and HIV co-infection an emerging consensus.
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26270.
    PubMed     Abstract available


  330. MARIMUTHU J, Kumar BS, Aravind Gandhi P
    HIV and SARS CoV-2 co-infection: A retrospective, record based, case series from South India.
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26271.
    PubMed     Abstract available


  331. NAKAMURA H, Miyagi K, Otsuki M, Higure Y, et al
    Serum KL-6 can distinguish between different phenotypes of severe COVID-19.
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26268.
    PubMed     Abstract available


  332. BAUER G
    The variability of the serological response to SARS corona virus-2: Potential resolution of ambiguity through determination of avidity (functional affinity).
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26262.
    PubMed     Abstract available


  333. WANG Y, Anirudhan V, Du R, Cui Q, et al
    RNA-dependent RNA Polymerase of SARS-CoV-2 as a Therapeutic Target.
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26264.
    PubMed     Abstract available


  334. MIAH MA, Husna A
    Co-infection, co-epidemics of Covid-19 and Dengue in dengue endemic countries: a serious health concern.
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26269.
    PubMed     Abstract available


  335. MALAIYAN J, Arumugam S, Mohan K, Radhakrishnan GG, et al
    An update on origin of SARS-CoV-2: Despite closest identity, bat (RaTG13) and Pangolin derived Coronaviruses varied in the critical binding site and O-linked glycan residues.
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26261.
    PubMed     Abstract available


  336. YU C, Zhang Z, Guo Y, Shi J, et al
    Lopinavir/ritonavir is associated with pneumonia resolution in COVID-19 patients with influenza coinfection: a retrospective matched-pair cohort study.
    J Med Virol. 2020 Jul 4. doi: 10.1002/jmv.26260.
    PubMed     Abstract available


  337. MA L, Xie W, Li D, Shi L, et al
    Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients.
    J Med Virol. 2020 Jul 4. doi: 10.1002/jmv.26259.
    PubMed     Abstract available


  338. LEUNG EC, Chow VC, Lee MK, Lai RW, et al
    Deep throat saliva as an alternative diagnostic specimen type for the detection of SARS-CoV-2.
    J Med Virol. 2020 Jul 4. doi: 10.1002/jmv.26258.
    PubMed     Abstract available


  339. SAHU KK, Siddiqui AD, Rezaei N, Cerny J, et al
    Challenges for management of immune thrombocytopenia during COVID-19 pandemic.
    J Med Virol. 2020 Jul 3. doi: 10.1002/jmv.26251.
    PubMed    


  340. PRZYDZIAL P, Tchomobe G, Amin K, Christian E, et al
    When COVID-19 Crosses Paths with AIDS in the Homeless.
    J Med Virol. 2020 Jul 3. doi: 10.1002/jmv.26255.
    PubMed     Abstract available


  341. BELINGHERI M, Paladino ME, Piacenti S, Riva MA, et al
    Effects of COVID-19 lockdown on epidemic diseases of childhood.
    J Med Virol. 2020 Jul 3. doi: 10.1002/jmv.26253.
    PubMed    


  342. HUANG D, Yu H, Wang T, Yang H, et al
    Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
    J Med Virol. 2020 Jul 3. doi: 10.1002/jmv.26256.
    PubMed     Abstract available


  343. SINGH SP, Pritam M, Pandey B, Yadav TP, et al
    Microstructure, pathophysiology and potential therapeutics of COVID-19: A comprehensive review.
    J Med Virol. 2020 Jul 3. doi: 10.1002/jmv.26254.
    PubMed     Abstract available


  344. SALACUP G, Lo KB, Gul F, Peterson E, et al
    Characteristics and Clinical Outcomes of COVID-19 Patients in an Underserved-Inner City Population: A Single Tertiary Center Cohort.
    J Med Virol. 2020 Jul 3. doi: 10.1002/jmv.26252.
    PubMed     Abstract available


  345. LI YC, Bai WZ, Hashikawa T
    Response to Commentary on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients".
    J Med Virol. 2020;92:707-709.
    PubMed     Abstract available


  346. PANIZ-MONDOLFI A, Bryce C, Grimes Z, Gordon RE, et al
    Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
    J Med Virol. 2020;92:699-702.
    PubMed     Abstract available


  347. ZHU J, Zhong Z, Li H, Ji P, et al
    CT imaging features of 4121 patients with COVID-19: A meta-analysis.
    J Med Virol. 2020;92:891-902.
    PubMed     Abstract available


  348. TAN C, Huang Y, Shi F, Tan K, et al
    C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early.
    J Med Virol. 2020;92:856-862.
    PubMed     Abstract available


  349. TURTLE L
    Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2.
    J Med Virol. 2020;92:705-706.
    PubMed    


  350. LI Y, Yao L, Li J, Chen L, et al
    Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19.
    J Med Virol. 2020;92:903-908.
    PubMed     Abstract available


  351. CHEN Y, Li Z, Zhang YY, Zhao WH, et al
    Maternal health care management during the outbreak of coronavirus disease 2019.
    J Med Virol. 2020;92:731-739.
    PubMed     Abstract available


  352. HAN Z, Battaglia F, Terlecky SR
    Discharged COVID-19 Patients Testing Positive Again for SARS-CoV-2 RNA: A Minireview of Published Studies from China.
    J Med Virol. 2020 Jul 1. doi: 10.1002/jmv.26250.
    PubMed     Abstract available


    June 2020
  353. ZENG Z, Ma Y, Zeng H, Huang P, et al
    Simple nomogram based on initial laboratory data for predicting the probability of ICU transfer of COVID-19 patients: Multicenter retrospective study.
    J Med Virol. 2020 Jun 30. doi: 10.1002/jmv.26244.
    PubMed     Abstract available


  354. RONG Y, Wang F, Liu J, Zhou Y, et al
    Clinical characteristics and risk factors of mild-to-moderate COVID-19 patients with false negative SARS-CoV-2 nucleic acid.
    J Med Virol. 2020 Jun 30. doi: 10.1002/jmv.26242.
    PubMed     Abstract available


  355. FALAHI S, Kenarkoohi A
    Sex and gender differences in the outcome of patients with COVID-19.
    J Med Virol. 2020 Jun 30. doi: 10.1002/jmv.26243.
    PubMed     Abstract available


  356. HAQQI A, Zahoor S, Aftab MN, Tipu I, et al
    COVID-19 in Pakistan; Impact on Global Polio Eradication Initiative.
    J Med Virol. 2020 Jun 30. doi: 10.1002/jmv.26240.
    PubMed     Abstract available


  357. LIU A, Li Y, Peng J, Huang Y, et al
    Antibody responses against SARS-CoV-2 in COVID-19 patients.
    J Med Virol. 2020 Jun 30. doi: 10.1002/jmv.26241.
    PubMed     Abstract available


  358. SHI S, Su M, Shen G, Hu Y, et al
    Matrix Metalloproteinase 3 as a Valuable Marker for Patients with COVID-19.
    J Med Virol. 2020 Jun 30. doi: 10.1002/jmv.26235.
    PubMed     Abstract available


  359. YANG J, Hu J, Zhu C
    Obesity aggravates COVID-19: a systematic review and meta-analysis.
    J Med Virol. 2020 Jun 30. doi: 10.1002/jmv.26237.
    PubMed     Abstract available


  360. CHERUIYOT I
    Comment on "Encephalopathy in patients with COVID-19: A review".
    J Med Virol. 2020 Jun 30. doi: 10.1002/jmv.26238.
    PubMed     Abstract available


  361. BENEDETTI F, Pachetti M, Marini B, Ippodrino R, et al
    SARS-CoV-2: march toward adaptation.
    J Med Virol. 2020 Jun 29. doi: 10.1002/jmv.26233.
    PubMed     Abstract available


  362. YAN M, Zheng Y, Sun Y, Wang L, et al
    Analysis of the diagnostic value of serum specific antibody testing for coronavirus disease 2019.
    J Med Virol. 2020 Jun 27. doi: 10.1002/jmv.26230.
    PubMed     Abstract available


  363. HU B, Huang S, Yin L
    The cytokine storm and COVID-19.
    J Med Virol. 2020 Jun 27. doi: 10.1002/jmv.26232.
    PubMed     Abstract available


  364. HERNANDEZ-HUERTA MT, Mayoral LP, Navarro LMS, Mayoral-Andrade G, et al
    Should RT-PCR be considered a gold standard in the diagnosis of Covid-19?
    J Med Virol. 2020 Jun 27. doi: 10.1002/jmv.26228.
    PubMed     Abstract available


  365. BETTACH E, Zadok D, Weill Y, Brosh K, et al
    Bilateral anterior uveitis as a part of a multisystem inflammatory syndrome secondary to COVID-19 infection.
    J Med Virol. 2020 Jun 27. doi: 10.1002/jmv.26229.
    PubMed     Abstract available


  366. SMITH SM, Boppana A, Traupman JA, Unson E, et al
    Impaired glucose metabolism in patients with diabetes, prediabetes and obesity is associated with severe Covid-19.
    J Med Virol. 2020 Jun 26. doi: 10.1002/jmv.26227.
    PubMed     Abstract available


  367. ZHAO Y, Zhou J, Pan L, Zhang Y, et al
    Detection and analysis of clinical features of patients with different COVID-19 types.
    J Med Virol. 2020 Jun 26. doi: 10.1002/jmv.26225.
    PubMed     Abstract available


  368. RIOLLANO-CRUZ M, Akkoyun E, Briceno-Brito E, Kowalsky S, et al
    Multisystem Inflammatory Syndrome in Children (MIS-C) Related to COVID-19: A New York City Experience.
    J Med Virol. 2020 Jun 25. doi: 10.1002/jmv.26224.
    PubMed     Abstract available


  369. RUAN L, Zhang Y, Luo Y, Yu X, et al
    Clinical features and outcomes of four HIV patients with COVID-19 in Wuhan, China.
    J Med Virol. 2020 Jun 25. doi: 10.1002/jmv.26223.
    PubMed     Abstract available


  370. MOHAPATRA PR, Mishra B, Behera B
    Immunity and Protection from COVID-19 - Environmental Mycobacteria play a role.
    J Med Virol. 2020 Jun 24. doi: 10.1002/jmv.26214.
    PubMed     Abstract available


  371. GIMENEZ E, Albert E, Torres I, Remigia MJ, et al
    SARS-CoV-2-reactive interferon-gamma-producing CD8(+) T cells in patients hospitalized with Coronavirus Disease 2019.
    J Med Virol. 2020 Jun 24. doi: 10.1002/jmv.26213.
    PubMed     Abstract available


  372. GUEMES-VILLAHOZ N, Burgos-Blasco B, Vilela AA, Arriola-Villalobos P, et al
    Detecting SARS-CoV-2 RNA in conjunctival secretions: is it a valuable diagnostic method of COVID-19?
    J Med Virol. 2020 Jun 24. doi: 10.1002/jmv.26219.
    PubMed     Abstract available


  373. RUAN Z, Liu C, Guo Y, He Z, et al
    SARS-CoV-2 and SARS-CoV: Virtual Screening of Potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12).
    J Med Virol. 2020 Jun 24. doi: 10.1002/jmv.26222.
    PubMed     Abstract available


  374. LUCCHESI A, Silimbani P, Musuraca G, Cerchione C, et al
    Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease.
    J Med Virol. 2020 Jun 24. doi: 10.1002/jmv.26217.
    PubMed     Abstract available


  375. CICCARESE G, Drago F, Boatti M, Porro A, et al
    Oral erosions and petechiae during SARS-CoV-2 infection.
    J Med Virol. 2020 Jun 24. doi: 10.1002/jmv.26221.
    PubMed     Abstract available


  376. ZHENG Y, Wang L, Ben S
    Meta-analysis of chest CT features of patients with COVID-19 pneumonia.
    J Med Virol. 2020 Jun 24. doi: 10.1002/jmv.26218.
    PubMed     Abstract available


  377. MIYAZAWA D
    Why obesity, hypertension, diabetes, and ethnicities are common risk factors for COVID-19 and H1N1 influenza infections.
    J Med Virol. 2020 Jun 24. doi: 10.1002/jmv.26220.
    PubMed     Abstract available


  378. BAIG AM, Khaleeq A, Hira S
    Elucidation of Cellular Targets and Exploitation of the Receptor Binding Domain of SARS-CoV-2 for vaccine and monoclonal antibody synthesis.
    J Med Virol. 2020 Jun 23. doi: 10.1002/jmv.26212.
    PubMed     Abstract available


  379. NG KF, Kothari T, Bandi S, Bird PW, et al
    COVID-19 Multisystem Inflammatory Syndrome in Three Teenagers with Confirmed SARS-CoV-2 Infection.
    J Med Virol. 2020 Jun 22. doi: 10.1002/jmv.26206.
    PubMed     Abstract available


  380. ZHANG ZL, Hou YL, Li DT, Li FZ, et al
    Diagnostic efficacy of anti-SARS-CoV-2 IgG/IgM test for Covid-19: A meta-analysis.
    J Med Virol. 2020 Jun 22. doi: 10.1002/jmv.26211.
    PubMed     Abstract available


  381. ANDRIANOPOULOS I, Papathanasiou A, Papathanakos G, Chaidos A, et al
    Tocilizumab's efficacy in COVID-19 patients is determined by the presence of cytokine storm.
    J Med Virol. 2020 Jun 22. doi: 10.1002/jmv.26209.
    PubMed     Abstract available


  382. WENG CH, Saal A, Butt WWW, Chan PA, et al
    Characteristics and Clinical Course and Outcome of COVID-19 in Hispanic/Latino Patients in a Community Setting: A Retrospective Cohort Study.
    J Med Virol. 2020 Jun 19. doi: 10.1002/jmv.26196.
    PubMed     Abstract available


  383. CARDONA-OSPINA JA, Arteaga-Livias K, Villamil-Gomez WE, Perez-Diaz CE, et al
    Dengue and COVID-19, overlapping epidemics? An Analysis from Colombia.
    J Med Virol. 2020 Jun 19. doi: 10.1002/jmv.26194.
    PubMed     Abstract available


  384. SICA A, Casale D, Rossi G, Casale B, et al
    The impact of the SARS-CoV-2 infection, with special reference to the haematological setting.
    J Med Virol. 2020 Jun 19. doi: 10.1002/jmv.26197.
    PubMed     Abstract available


  385. MUHAMMAD MOOSA M, Banerjee PR
    Subversion of host stress granules by coronaviruses: Potential roles of pi-rich disordered domains of viral nucleocapsids.
    J Med Virol. 2020 Jun 19. doi: 10.1002/jmv.26195.
    PubMed     Abstract available


  386. GARG RK, Paliwal VK, Gupta A
    Encephalopathy in patients with COVID-19: A review.
    J Med Virol. 2020 Jun 19. doi: 10.1002/jmv.26207.
    PubMed     Abstract available


  387. MA X, Liu S, Chen L, Zhuang L, et al
    The clinical characteristics of pediatric inpatients with SARS-CoV-2 infection: a meta-analysis and systematic review.
    J Med Virol. 2020 Jun 19. doi: 10.1002/jmv.26208.
    PubMed     Abstract available


  388. WONG J, Koh WC, Momin RN, Alikhan MF, et al
    Probable causes and risk factors for positive SARS-CoV-2 test in recovered patients: Evidence from Brunei Darussalam.
    J Med Virol. 2020 Jun 19. doi: 10.1002/jmv.26199.
    PubMed     Abstract available


  389. LIAO Y, Li X, Mou T, Zhou X, et al
    Distinct infection process of SARS-CoV-2 in human bronchial epithelial cells line.
    J Med Virol. 2020 Jun 19. doi: 10.1002/jmv.26200.
    PubMed     Abstract available


  390. LI Y, Li C, Wang J, Zhu C, et al
    A case series of COVID-19 patients with chronic hepatitis B virus infection.
    J Med Virol. 2020 Jun 19. doi: 10.1002/jmv.26201.
    PubMed     Abstract available


  391. KNORR JP, Colomy V, Mauriello CM, Ha S, et al
    Tocilizumab in patients with severe COVID-19: A single-center observational analysis.
    J Med Virol. 2020 Jun 17. doi: 10.1002/jmv.26191.
    PubMed     Abstract available


  392. GIULIANI J, Bonetti A
    Cancer prevales on COVID-19: To maintain high quality standard concerning diagnosis and oncological care even during a pandemic.
    J Med Virol. 2020 Jun 17. doi: 10.1002/jmv.26190.
    PubMed    


  393. WANG G, Yu N, Xiao W, Zhao C, et al
    Consecutive false-negative rRT-PCR test results for SARS-CoV-2 in patients after clinical recovery from COVID-19.
    J Med Virol. 2020 Jun 17. doi: 10.1002/jmv.26192.
    PubMed     Abstract available


  394. XUE H, Liu Y, Luo P, Liu X, et al
    Hydroxychloroquine treatment in COVID-19: a descriptive observational analysis of 30 cases from a single center in Wuhan, China.
    J Med Virol. 2020 Jun 17. doi: 10.1002/jmv.26193.
    PubMed     Abstract available


  395. GIANNATTASIO A, Maglione M, Zenzeri L, Mauro A, et al
    A child with a severe multisystem inflammatory syndrome following an asymptomatic COVID-19 infection: A novel management for a new disease?
    J Med Virol. 2020 Jun 17. doi: 10.1002/jmv.26189.
    PubMed    


  396. WEI Y, Lu Y, Xia L, Yuan X, et al
    Analysis of 2019 novel coronavirus infection and clinical characteristics of outpatients: An epidemiological study from a fever clinic in Wuhan, China.
    J Med Virol. 2020 Jun 16. doi: 10.1002/jmv.26175.
    PubMed     Abstract available


  397. HE J, Hu P, Gao Y, Zheng S, et al
    Comparison and Application of Different Immunoassay Methods for the Detection of SARS-CoV-2.
    J Med Virol. 2020 Jun 16. doi: 10.1002/jmv.26187.
    PubMed     Abstract available


  398. WEI LL, Wang WJ, Chen DX, Xu B, et al
    Dysregulation of the immune response affects the outcome of critical COVID-19 patients.
    J Med Virol. 2020 Jun 16. doi: 10.1002/jmv.26181.
    PubMed     Abstract available


  399. MEYERS KJ, Jones ME, Goetz IA, Botros FT, et al
    A cross-sectional community-based observational study of asymptomatic SARS-CoV-2 prevalence in the greater Indianapolis area.
    J Med Virol. 2020 Jun 16. doi: 10.1002/jmv.26182.
    PubMed     Abstract available


  400. YE C, Zhang S, Zhang X, Cai H, et al
    Impact of comorbidities on patients with COVID-19: A large retrospective study in Zhejiang, China.
    J Med Virol. 2020 Jun 16. doi: 10.1002/jmv.26183.
    PubMed     Abstract available


  401. HUA CZ, Miao ZP, Zheng JS, Huang Q, et al
    Epidemiological features and viral shedding in children with SARS-CoV-2 infection.
    J Med Virol. 2020 Jun 15. doi: 10.1002/jmv.26180.
    PubMed     Abstract available


  402. TOOMBS JM, Van den Abbeele K, Democratis J, Merricks R, et al
    COVID-19 in 3 people living with HIV in the United Kingdom.
    J Med Virol. 2020 Jun 15. doi: 10.1002/jmv.26178.
    PubMed     Abstract available


  403. ARANDA-ABREU GE, Aranda-Martinez JD, Araujo R
    Use of amantadine in a patient with SARS-Cov-2.
    J Med Virol. 2020 Jun 15. doi: 10.1002/jmv.26179.
    PubMed     Abstract available


  404. PATEL RH
    Clinical Outcomes and Prognosis of Patients with HIV and SARS-CoV-2 Co-infection.
    J Med Virol. 2020 Jun 15. doi: 10.1002/jmv.26177.
    PubMed     Abstract available


  405. HUANG H, Zhang M, Chen C, Zhang H, et al
    Clinical Characteristics of COVID-19 in patients with pre-existing ILD: A retrospective study in a single center in Wuhan, China.
    J Med Virol. 2020 Jun 13. doi: 10.1002/jmv.26174.
    PubMed     Abstract available


  406. FANG Y
    Large-scale National Screening for COVID-19 in China.
    J Med Virol. 2020 Jun 13. doi: 10.1002/jmv.26173.
    PubMed     Abstract available


  407. ALLALI G, Marti C, Grosgurin O, Morelot-Panzini C, et al
    Dyspnea: the vanished warning symptom of COVID-19 pneumonia.
    J Med Virol. 2020 Jun 12. doi: 10.1002/jmv.26172.
    PubMed     Abstract available


  408. ANTONY SJ, Almaghlouth NK, Heydemann EL
    Are co-infections with COVID-19 and Influenza low or underreported? An observational study examining current published literature including three new unpublished cases.
    J Med Virol. 2020 Jun 12. doi: 10.1002/jmv.26167.
    PubMed     Abstract available


  409. HAN D, Fang Q, Wang X
    SARS-CoV-2 was found in the bile juice from a patient with severe COVID-19.
    J Med Virol. 2020 Jun 12. doi: 10.1002/jmv.26169.
    PubMed     Abstract available


  410. TORAIH EA, Elshazli RM, Hussein MH, Elgaml A, et al
    Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID-19 patients: A meta-regression and Decision tree analysis.
    J Med Virol. 2020 Jun 12. doi: 10.1002/jmv.26166.
    PubMed     Abstract available


  411. KOLILEKAS L, Loverdos K, Giannakaki S, Vlassi L, et al
    Can steroids reverse the severe COVID-19 induced 'cytokine storm'?
    J Med Virol. 2020 Jun 12. doi: 10.1002/jmv.26165.
    PubMed     Abstract available


  412. CIMOLAI N
    Environmental and Decontamination Issues for Human Coronaviruses and Their Potential Surrogates.
    J Med Virol. 2020 Jun 12. doi: 10.1002/jmv.26170.
    PubMed     Abstract available


  413. YUE H, Zhang M, Xing L, Wang K, et al
    The epidemiology and clinical characteristics of co-infection of SARS-CoV-2 and influenza viruses in patients during COVID-19 outbreak.
    J Med Virol. 2020 Jun 12. doi: 10.1002/jmv.26163.
    PubMed     Abstract available


  414. WU Y, Guo W, Liu H, Qi B, et al
    Clinical outcomes of 402 patients with COVID-2019 from a single center in Wuhan, China.
    J Med Virol. 2020 Jun 12. doi: 10.1002/jmv.26168.
    PubMed     Abstract available


  415. FUKADA A, Kitagawa Y, Matsuoka M, Sakai J, et al
    Presepsin as a predictive biomarker of severity in COVID-19: a case series.
    J Med Virol. 2020 Jun 12. doi: 10.1002/jmv.26164.
    PubMed     Abstract available


  416. SON HA, Hang DTT, Thuan ND, Quyen LTB, et al
    A Simple Method for Detection of a Novel Coronavirus (SARS-CoV-2) using One-step RT-PCR followed by Restriction Fragment Length Polymorphism.
    J Med Virol. 2020 Jun 12. doi: 10.1002/jmv.26171.
    PubMed     Abstract available


  417. CHEN JM, Sun YX, Chen JW
    Potential for elimination of SAR-CoV-2 through vaccination as inspired by elimination of multiple influenza viruses through natural pandemics or mass vaccination.
    J Med Virol. 2020 Jun 11. doi: 10.1002/jmv.26162.
    PubMed     Abstract available


  418. TAN BH, Zhang Y, Gui Y, Wu S, et al
    The possible impairment of respiratory-related neural loops may be associated with the silent pneumonia induced by SARS-CoV-2.
    J Med Virol. 2020 Jun 11. doi: 10.1002/jmv.26158.
    PubMed     Abstract available


  419. DZINAMARIRA T, Dzobo M, Chitungo I
    Covid-19: A Perspective on Africa's Capacity and Response.
    J Med Virol. 2020 Jun 11. doi: 10.1002/jmv.26159.
    PubMed     Abstract available


  420. BENTIVEGNA E, Sentimentale A, Luciani M, Speranza ML, et al
    New IgM seroconversion and positive RT-PCR test after exposure to the virus in recovered COVID-19 patient.
    J Med Virol. 2020 Jun 11. doi: 10.1002/jmv.26160.
    PubMed     Abstract available


  421. ABOBAKER A, Raba AA, Alzwi A
    Extrapulmonary and atypical clinical presentations of COVID-19.
    J Med Virol. 2020 Jun 10. doi: 10.1002/jmv.26157.
    PubMed     Abstract available


  422. HERLEKAR R, Roy AS, Matson M
    Hypoalbuminaemia in COVID-19 infection: a predictor of severity or a potential therapeutic target?
    J Med Virol. 2020 Jun 10. doi: 10.1002/jmv.26151.
    PubMed     Abstract available


  423. BAHLOUL M, Ketata W, Lahyeni D, Mayoufi H, et al
    Pulmonary Capillary Leak Syndrome following COVID-19 Virus Infection.
    J Med Virol. 2020 Jun 10. doi: 10.1002/jmv.26152.
    PubMed     Abstract available


  424. LUO W, Zhang JW, Zhang W, Lin YL, et al
    Circulating Levels of IL-2, IL-4, TNF-alpha, IFN-gamma and C reactive protein Are Not Associated with Severity of COVID-19 Symptoms.
    J Med Virol. 2020 Jun 10. doi: 10.1002/jmv.26156.
    PubMed     Abstract available


  425. SUWANWONGSE K, Shabarek N
    Hyperpyrexia in COVID-19 patients.
    J Med Virol. 2020 Jun 10. doi: 10.1002/jmv.26154.
    PubMed     Abstract available


  426. KOW CS, Hasan SS
    Could melatonin be used in COVID-19 patients with laryngopharyngeal reflux disease?
    J Med Virol. 2020 Jun 10. doi: 10.1002/jmv.26150.
    PubMed     Abstract available


  427. LI W, Ma Q, Wang X, Tang M, et al
    Letter to the Editor: The characteristics of two patients co-infected with SARS-CoV-2 and HIV in Wuhan, China.
    J Med Virol. 2020 Jun 10. doi: 10.1002/jmv.26155.
    PubMed     Abstract available


  428. SCHILLER M, Wydra S, Kerl HU, Kick W, et al
    Diagnosis of COVID-19 pneumonia despite missing detection of viral nucleic acid and initially inconspicuous radiologic findings.
    J Med Virol. 2020 Jun 10. doi: 10.1002/jmv.26153.
    PubMed     Abstract available


  429. BIAGI A, Rossi L, Malagoli A, Zanni A, et al
    Clinical and epidemiological characteristics of 320 deceased Covid-19 patients in an Italian Province: a retrospective observational study.
    J Med Virol. 2020 Jun 9. doi: 10.1002/jmv.26147.
    PubMed     Abstract available


  430. QUARTUCCIO L, Sonaglia A, Pecori D, Peghin M, et al
    Higher levels of IL-6 early after tocilizumab distinguish survivors from non-survivors in COVID-19 pneumonia: a possible indication for deeper targeting IL-6.
    J Med Virol. 2020 Jun 9. doi: 10.1002/jmv.26149.
    PubMed     Abstract available


  431. HAQQI A, Awan UA, Ali M, Saqib MAN, et al
    COVID-19 and dengue virus co-epidemics in Pakistan: A dangerous combination for overburdened healthcare system.
    J Med Virol. 2020 Jun 8. doi: 10.1002/jmv.26144.
    PubMed     Abstract available


  432. ZHENG T, Yang C, Wang HY, Chen X, et al
    Clinical characteristics and outcomes of COVID-19 patients with gastrointestinal symptoms admitted to Jianghan Fangcang Shelter Hospital in Wuhan, China.
    J Med Virol. 2020 Jun 8. doi: 10.1002/jmv.26146.
    PubMed     Abstract available


  433. CHEN W, Yao M, Fang Z, Lv X, et al
    A study on clinical effect of Arbidol combined with adjuvant therapy on COVID-19.
    J Med Virol. 2020 Jun 8. doi: 10.1002/jmv.26142.
    PubMed     Abstract available


  434. KOHMER N, Westhaus S, Ruhl C, Ciesek S, et al
    Clinical performance of different SARS-CoV-2 IgG antibody tests.
    J Med Virol. 2020 Jun 8. doi: 10.1002/jmv.26145.
    PubMed     Abstract available


  435. HUANG D, Wang T, Chen Z, Yang H, et al
    A novel risk score to predict diagnosis with Coronavirus Disease 2019 (COVID-19) in suspected patients: A retrospective, multi-center, observational study.
    J Med Virol. 2020 Jun 8. doi: 10.1002/jmv.26143.
    PubMed     Abstract available


  436. ZHANG Z, Wang S, Tu X, Peng X, et al
    A comparative study on the time to achieve negative nucleic acid testing and hospital stays between Danoprevir and Lopinavir/Ritonavir in the treatment of patients with COVID-19.
    J Med Virol. 2020 Jun 5. doi: 10.1002/jmv.26141.
    PubMed     Abstract available


  437. CHAN WM, Ip JD, Chu AW, Yip CC, et al
    Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole genome sequencing.
    J Med Virol. 2020 Jun 5. doi: 10.1002/jmv.26140.
    PubMed     Abstract available


  438. MURT A, Eskazan AE, Yilmaz U, Ozkan T, et al
    COVID-19 presenting with immune thrombocytopenia: a case report and review of the literature.
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26138.
    PubMed     Abstract available


  439. GRAJEWSKI RS, Rokohl AC, Becker M, Dewald F, et al
    Letter to the Editor: A Missing Link between SARS-CoV-2 and the Eye?: ACE2 Expression on the Ocular Surface.
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26136.
    PubMed     Abstract available


  440. ZHUANG MW, Cheng Y, Zhang J, Jiang XM, et al
    Increasing Host Cellular Receptor-Angiotensin-Converting Enzyme 2 (ACE2) Expression by Coronavirus may Facilitate 2019-nCoV (or SARS-CoV-2) Infection.
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26139.
    PubMed     Abstract available


  441. BRUNO G, Fabrizio C, Santoro CR, Buccoliero GB, et al
    Pancreatic injury in the course of coronavirus disease 2019 (COVID-19): a not-so-rare occurrence.
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26134.
    PubMed     Abstract available


  442. QIN L, Li X, Shi J, Yu M, et al
    Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan.
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26137.
    PubMed     Abstract available


  443. ROMERO PE
    Comment on "Genetic variants and source of introduction of SARS-CoV-2 in South America".
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26122.
    PubMed     Abstract available


  444. MARIN-HERNANDEZ D, Schwartz RE, Nixon DF
    Epidemiological Evidence for Association between Higher Influenza Vaccine Uptake in the Elderly and Lower COVID-19 Deaths in Italy.
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26120.
    PubMed     Abstract available


  445. FINSTERER J, Scorza FA, Ghosh R
    COVID-19 polyradiculitis in 24 patients without SARS-CoV-2 in the cerebro-spinal fluid.
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26121.
    PubMed     Abstract available


  446. MANRIQUE JV, Ghosh K, Boma N
    Anticardiolipin antibodies and COVID-19 - A Case Report from America.
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26135.
    PubMed     Abstract available


  447. OZARAS R, Cirpin R, Duran A, Duman H, et al
    Influenza and COVID-19 Co-infection: Report of 6 cases and review of the Literature.
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26125.
    PubMed     Abstract available


  448. ADADI P, Kanwugu ON
    Living with HIV in the time of COVID-19: a glimpse of hope.
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26118.
    PubMed     Abstract available


  449. KANG H, Wang Y, Tong Z, Liu X, et al
    Re-test Positive for SARS-CoV-2 RNA of "Recovered" Patients with COVID-19: Persistence, Sampling issues, or Re-infection?
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26114.
    PubMed     Abstract available


  450. ZUO Y, Liu Y, Zhong Q, Zhang K, et al
    Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID-19: a retrospective study in two designated hospitals in Anhui, China.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26127.
    PubMed     Abstract available


  451. SHABANI M, Shokouhi S, Moradi O, Saffaei A, et al
    Tocilizumab Administration in Patients with SARS-CoV-2 Infection: Subcutaneous Injection versus Intravenous Infusion.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26124.
    PubMed     Abstract available


  452. IKITIMUR H, Borku Uysal B, Cengiz M, Ikitimur B, et al
    ''Determining Host Factors Contributing to Disease Severity in a Family Cluster of 29 Hospitalized SARS-CoV-2 Patients: Could Genetic Factors Be Relevant in the Clinical Course of COVID-19?''.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26106.
    PubMed     Abstract available


  453. UL ALAM ASMR, Rafiul Islam M, Shaminur Rahman M, Islam OK, et al
    Understanding the possible origin and genotyping of first Bangladeshi SARS-CoV-2 strain.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26115.
    PubMed     Abstract available


  454. YU T, Tian C, Chu S, Zhou H, et al
    COVID-19 patients benefit from early antiviral treatment: a comparative, retrospective study.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26129.
    PubMed     Abstract available


  455. SAGKAN RI, Akin-Bali DF
    Structural variations and expression profiles of the SARS-CoV-2 host invasion genes in Lung cancer.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26107.
    PubMed     Abstract available


  456. AKINOSOGLOU K, Velissaris D, Ziazias D, Davoulos C, et al
    Remdesivir and Tocilizumab: Mix or Match.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26117.
    PubMed     Abstract available


  457. CARNEVALE S, Beretta P, Morbini P
    Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of CoViD-19 patient with diarrhea.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26119.
    PubMed     Abstract available


  458. LOTFI M, Rezaei N
    SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26123.
    PubMed     Abstract available


  459. WEN S, Sun C, Zheng H, Wang L, et al
    High-Coverage SARS-CoV-2 Genome Sequences Acquired by Target Capture Sequencing.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26116.
    PubMed     Abstract available


  460. CRUZ JO, Conceicao IMCA, Sousa SMB, Luizon MR, et al
    Functional prediction and frequency of coding variants in human ACE2 at binding sites with SARS-CoV-2 spike protein on different populations.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26126.
    PubMed     Abstract available


  461. BAIG AM, Sanders EC
    Potential Neuroinvasive Pathways of SARS-CoV-2: Deciphering the Spectrum of Neurological Deficit Seen in Coronavirus Disease 2019 (COVID-19).
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26105.
    PubMed     Abstract available


  462. NAKAMOTO T, Kutsuna S, Yanagawa Y, Kanda K, et al
    A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26102.
    PubMed     Abstract available


  463. BENVENUTO D, Demir AB, Giovanetti M, Bianchi M, et al
    Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26104.
    PubMed     Abstract available


  464. ELGAMASY S, Kamel MG, Ghozy S, Khalil A, et al
    First Case of Focal Epilepsy Associated with SARS-Coronavirus-2.
    J Med Virol. 2020 Jun 2. doi: 10.1002/jmv.26113.
    PubMed     Abstract available


  465. AIKAWA T, Takagi H, Ishikawa K, Kuno T, et al
    Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: an insight from a meta-analysis.
    J Med Virol. 2020 Jun 2. doi: 10.1002/jmv.26108.
    PubMed     Abstract available


  466. CARMO A, Pereira-Vaz J, Mota V, Mendes A, et al
    Clearance and Persistence of SARS-CoV-2 RNA in COVID-19 patients.
    J Med Virol. 2020 Jun 2. doi: 10.1002/jmv.26103.
    PubMed     Abstract available


  467. ALBERT E, Ferrer B, Torres I, Serrano A, et al
    Amplification of human beta-glucoronidase gene for appraising the accuracy of negative SARS-CoV-2 RT-PCR results in upper respiratory tract specimens.
    J Med Virol. 2020 Jun 2. doi: 10.1002/jmv.26112.
    PubMed     Abstract available


  468. BELEC L, Pere H, Bouassa RM, Veyer D, et al
    Potential pitfalls of routine SARS-CoV-2 serology for mass screening.
    J Med Virol. 2020 Jun 2. doi: 10.1002/jmv.26034.
    PubMed     Abstract available


  469. BORKU UYSAL B, Ikitimur H, Yavuzer S, Ikitimur B, et al
    ''Tociluzumab challenge: A series of cytokine storm therapy experience in hospitalized Covid-19 pneumonia patients''.
    J Med Virol. 2020 Jun 2. doi: 10.1002/jmv.26111.
    PubMed     Abstract available


  470. ISSA N, Dumery M, Guisset O, Mourissoux G, et al
    Feasibility of Tocilizumab in ICU patients with COVID-19.
    J Med Virol. 2020 Jun 2. doi: 10.1002/jmv.26110.
    PubMed     Abstract available


  471. LIU X, Mondal AM
    Conditional Cell Reprogramming for Modeling Host-Virus Interactions and Human Viral Diseases.
    J Med Virol. 2020 Jun 1. doi: 10.1002/jmv.26093.
    PubMed     Abstract available


  472. SAHU KK, Lal A, Mishra AK
    Latest updates on COVID-2019: A changing paradigm shift.
    J Med Virol. 2020;92:533-535.
    PubMed    


  473. ANGELETTI S, Benvenuto D, Bianchi M, Giovanetti M, et al
    COVID-2019: The role of the nsp2 and nsp3 in its pathogenesis.
    J Med Virol. 2020;92:584-588.
    PubMed     Abstract available


    May 2020
  474. PALMIERI B, Vadala M, Roncati L, Garelli A, et al
    The Long-Standing History of Corynebacterium Parvum, Immunity and Viruses.
    J Med Virol. 2020 May 30. doi: 10.1002/jmv.26100.
    PubMed     Abstract available


  475. BENUCCI M, Giannasi G, Cecchini P, Gobbi FL, et al
    COVID-19 pneumonia treated with Sarilumab: a clinical series of eight patients.
    J Med Virol. 2020 May 30. doi: 10.1002/jmv.26062.
    PubMed     Abstract available


  476. ALI N
    Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19.
    J Med Virol. 2020 May 30. doi: 10.1002/jmv.26097.
    PubMed    


  477. ZHANG B, Zhang J, Qian B, Han W, et al
    Comment on Han et al: Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China.
    J Med Virol. 2020 May 30. doi: 10.1002/jmv.26099.
    PubMed    


  478. PINKY L, Dobrovolny HM
    SARS-CoV-2 coinfections: Could influenza and the common cold be beneficial?
    J Med Virol. 2020 May 30. doi: 10.1002/jmv.26098.
    PubMed     Abstract available


  479. SEHRA ST, Fundin S, Lavery C, Baker JF, et al
    Differences in race and other state-level characteristics and associations with mortality from COVID-19 infection.
    J Med Virol. 2020 May 30. doi: 10.1002/jmv.26095.
    PubMed    


  480. CAI J, Sun W, Huang J, Gamber M, et al
    Clinical features and the treatment of children with COVID-19: A case series from Wenzhou, China.
    J Med Virol. 2020 May 30. doi: 10.1002/jmv.26092.
    PubMed    


  481. LIU M, Dai C, Lv X, Li B, et al
    Letter to the Editor: Are severe COVID-19 patients more susceptible to conjunctivitis?
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26084.
    PubMed     Abstract available


  482. SANCHEZ-DUQUE JA, Orozco-Hernandez JP, Marin-Medina DS, Cvetkovic-Vega A, et al
    Are we now observing an increasing number of coinfections between SARS-CoV-2 and other respiratory pathogens?
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26089.
    PubMed     Abstract available


  483. SIANG KC, Hasan SS
    Metformin use amid COVID-19 pandemic.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26090.
    PubMed     Abstract available


  484. DUAN J, Wang X, Chi J, Chen H, et al
    Correlation between the variables collected at admission and progression to severe cases during hospitalization among COVID-19 patients in Chongqing.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26082.
    PubMed     Abstract available


  485. MIRI SM, Noorbakhsh F, Mohebbi SR, Ghaemi A, et al
    Higher prevalence of asymptomatic or mild COVID-19 in children, claims and clues.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26069.
    PubMed     Abstract available


  486. BEZERRA RDS, Valenca IN, de Cassia Ruy P, Ximenez JPB, et al
    The Novel Coronavirus SARS-CoV-2: From a Zoonotic Infection to Coronavirus Disease-19 (COVID19).
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26072.
    PubMed     Abstract available


  487. LIU T, Wu S, Zeng G, Zhou F, et al
    Recurrent positive SARS-CoV-2 - immune certificate may not be valid.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26074.
    PubMed     Abstract available


  488. WANG CZ, Hu SL, Wang L, Li M, et al
    Early risk factors of the exacerbation of Coronavirus disease 2019 pneumonia.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26071.
    PubMed     Abstract available


  489. HE W, Yi GY, Zhu Y
    Estimation of the basic reproduction number, average incubation time, asymptomatic infection rate, and case fatality rate for COVID-19: Meta-analysis and sensitivity analysis.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26041.
    PubMed     Abstract available


  490. MA SQ, Zhang J, Wang YS, Xia J, et al
    Glucocorticoid therapy delays the clearance of SARS-CoV-2 RNA in an asymptomatic COVID-19 patient.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26086.
    PubMed     Abstract available


  491. LI T, Cheng GS, Pipavath S, Kicska G, et al
    The Novel Coronavirus Disease (COVID-19) Complicated by Pulmonary Embolism and Acute Respiratory Distress Syndrome.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26068.
    PubMed     Abstract available


  492. NI M, Tian FB, Xiang DD, Yu B, et al
    Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26070.
    PubMed     Abstract available


  493. KERBOUA KE
    The perplexing question of trained immunity versus adaptive memory in COVID-19.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26083.
    PubMed     Abstract available


  494. D'ALESSANDRO M, Cameli P, Refini RM, Bergantini L, et al
    Serum KL-6 concentrations as a novel biomarker of severe COVID19.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26087.
    PubMed     Abstract available


  495. ZHU J, Pang J, Ji P, Zhong Z, et al
    Elevated interleukin-6 is associated with severity of COVID-19: a meta-analysis.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26085.
    PubMed     Abstract available


  496. ZHENG Z, Yao Z, Wu K, Zheng J, et al
    The Diagnosis of SARS-CoV2 Pneumonia: A Review of Laboratory and Radiological Testing Results.
    J Med Virol. 2020 May 28. doi: 10.1002/jmv.26081.
    PubMed     Abstract available


  497. CHAKRABORTY C, Sharma AR, Bhattacharya M, Sharma G, et al
    COVID-19: Consider IL6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients.
    J Med Virol. 2020 May 28. doi: 10.1002/jmv.26078.
    PubMed     Abstract available


  498. PHAN LT, Nguyen TV, Huynh LKT, Dao MH, et al
    Clinical features, isolation, and complete genome sequence of severe acute respiratory syndrome coronavirus 2 from the first two patients in Vietnam.
    J Med Virol. 2020 May 28. doi: 10.1002/jmv.26075.
    PubMed     Abstract available


  499. LI ZT, Chen ZM, Chen LD, Zhan YQ, et al
    Coinfection with SARS-CoV-2 and other respiratory pathogens in COVID-19 patients in Guangzhou, China.
    J Med Virol. 2020 May 28. doi: 10.1002/jmv.26073.
    PubMed     Abstract available


  500. CIMOLAI N
    Features of Enteric Disease from Human Coronaviruses: Implications for COVID-19.
    J Med Virol. 2020 May 28. doi: 10.1002/jmv.26066.
    PubMed     Abstract available


  501. RIBEIRO VST, Telles JP, Tuon FF
    Arboviral diseases and COVID-19 in Brazil: Concerns regarding climatic, sanitation and endemic scenario.
    J Med Virol. 2020 May 28. doi: 10.1002/jmv.26079.
    PubMed     Abstract available


  502. LECHIEN JR, Bartaire E, Bobin F, Hans S, et al
    The Association between Laryngopharyngeal Reflux and COVID-19 is still not Demonstrated.
    J Med Virol. 2020 May 28. doi: 10.1002/jmv.26080.
    PubMed     Abstract available


  503. SUWANWONGSE K, Shabarek N
    Clinical features and outcome of HIV/SARS-CoV-2 co-infected patients in the Bronx, New York City.
    J Med Virol. 2020 May 28. doi: 10.1002/jmv.26077.
    PubMed     Abstract available


  504. BYRNES S, Bisen M, Syed B, Huda S, et al
    COVID-19 encephalopathy masquerading as substance withdrawal.
    J Med Virol. 2020 May 27. doi: 10.1002/jmv.26065.
    PubMed     Abstract available


  505. DING H, Deng W, Ding L, Ye X, et al
    Glycyrrhetinic acid and its derivatives as potential alternative medicine to relieve symptoms in non-hospitalized COVID-19 patients.
    J Med Virol. 2020 May 27. doi: 10.1002/jmv.26064.
    PubMed     Abstract available


  506. BRUFSKY A, Lotze MT
    Ratcheting Down the Virulence of SARS-CoV-2 in the COVID-19 Pandemic.
    J Med Virol. 2020 May 27. doi: 10.1002/jmv.26067.
    PubMed     Abstract available


  507. TEHERAN AA, Camero G, Hernandez C, Perez-Garcia L, et al
    Potential negative effects of the free use of chloroquine to manage COVID-19 in Colombia.
    J Med Virol. 2020 May 26. doi: 10.1002/jmv.26059.
    PubMed     Abstract available


  508. CHOE JY, Kim JW, Kwon HH, Hong HL, et al
    Diagnostic performance of immunochromatography assay for rapid detection of IgM and IgG in coronavirus disease 2019.
    J Med Virol. 2020 May 26. doi: 10.1002/jmv.26060.
    PubMed     Abstract available


  509. YAN X, Li F, Wang X, Yan J, et al
    Neutrophil to Lymphocyte Ratio as Prognostic and Predictive Factor in Patients with Coronavirus Disease 2019: A Retrospective Cross-sectional Study.
    J Med Virol. 2020 May 26. doi: 10.1002/jmv.26061.
    PubMed     Abstract available


  510. KANG CK, Choe PG, Park S, Kim TS, et al
    Compassionate use of hzVSF-v13 in two patients with severe COVID-19.
    J Med Virol. 2020 May 26. doi: 10.1002/jmv.26063.
    PubMed     Abstract available


  511. GAYAM V, Konala VM, Naramala S, Garlapati PR, et al
    Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA.
    J Med Virol. 2020 May 25. doi: 10.1002/jmv.26026.
    PubMed     Abstract available


  512. IORDANOU S, Koukios D, Matsentidou CT, Markoulaki D, et al
    Severe SARS-CoV-2 pneumonia in a 58-year-old patient with HIV: a clinical case report from the Republic of Cyprus.
    J Med Virol. 2020 May 25. doi: 10.1002/jmv.26053.
    PubMed     Abstract available


  513. HOANG VT, Dao TL, Gautret P
    Recurrence of positive SARS-CoV-2 in patients recovered from COVID-19.
    J Med Virol. 2020 May 25. doi: 10.1002/jmv.26056.
    PubMed     Abstract available


  514. YOUSSEF M, Hussein M, Attia AS, Elshazli R, et al
    COVID-19 and Liver Dysfunction: a systematic review and meta-analysis of retrospective studies.
    J Med Virol. 2020 May 23. doi: 10.1002/jmv.26055.
    PubMed     Abstract available


  515. SONG J, Li Y, Huang X, Chen Z, et al
    Systematic Analysis of ACE2 and TMPRSS2 Expression in Salivary Glands Reveals Underlying Transmission Mechanism Caused by SARS-CoV-2.
    J Med Virol. 2020 May 22. doi: 10.1002/jmv.26045.
    PubMed     Abstract available


  516. TIAN W, Jiang W, Yao J, Nicholson CJ, et al
    Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.
    J Med Virol. 2020 May 22. doi: 10.1002/jmv.26050.
    PubMed     Abstract available


  517. YANG Y, Zhao J, Wu J, Teng Y, et al
    A Rare Case of Immune Thrombocytopenic Purpura Secondary to COVID-19.
    J Med Virol. 2020 May 22. doi: 10.1002/jmv.26051.
    PubMed     Abstract available


  518. GONG Y, Guan L, Jin Z, Chen S, et al
    Effects of methylprednisolone use on viral genomic nucleic acid negative conversion and CT imaging lesion absorption in COVID-19 patients under 50 years old.
    J Med Virol. 2020 May 22. doi: 10.1002/jmv.26052.
    PubMed     Abstract available


  519. PATEL RH, Pella PM
    COVID-19 in a patient with HIV infection.
    J Med Virol. 2020 May 22. doi: 10.1002/jmv.26049.
    PubMed     Abstract available


  520. JI W, Li X
    Response to "Comments on "Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human" and "Codon bias analysis alone is uninformative for identifying host(s) of n
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26048.
    PubMed     Abstract available


  521. KARADAG E
    Increase in Covid-19 Cases and Case Fatality and Case Recovery Rates in Europe: A Cross Temporal Meta-Analysis.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26035.
    PubMed     Abstract available


  522. SAHU KK, Jindal V, Siddiqui AD, Cerny J, et al
    Convalescent Plasma Therapy: A Passive Therapy for An Aggressive COVID-19.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26047.
    PubMed     Abstract available


  523. LO CAPUTO S, Corso G, Clerici M, Santantonio TA, et al
    Baricitinib: a chance to treat COVID-19?
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26033.
    PubMed     Abstract available


  524. XI A, Zhuo M, Dai J, Ding Y, et al
    Epidemiological and clinical characteristics of discharged patients infected with SARS-CoV-2 on the Qinghai plateau.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26032.
    PubMed     Abstract available


  525. ZHANG F, Xiong Y, Wei Y, Hu Y, et al
    Obesity predisposes to the risk of higher mortality in young COVID-19 patients.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26039.
    PubMed     Abstract available


  526. ZHENG Z, Dong M, Hu K
    A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26040.
    PubMed     Abstract available


  527. TIAN D, Ye Q
    Hepatic complications of COVID-19 and its treatment.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26036.
    PubMed     Abstract available


  528. TARTAGLIONE M, Gamberini L, Semeraro F, Lupi C, et al
    COVID-19 suspicion and diagnosis: are we still chasing epidemiological criteria?
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26042.
    PubMed     Abstract available


  529. BALUKU JB, Mwebaza S, Ingabire G, Nsereko C, et al
    HIV and SARS-CoV-2 co-infection: A case report from Uganda.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26044.
    PubMed     Abstract available


  530. PERRONE S, Giordano M, Meoli A, Deolmi M, et al
    Lack of viral transmission to preterm newborn from a COVID-19 positive breastfeeding mother at 11 days postpartum.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26037.
    PubMed     Abstract available


  531. SHANG W, Dong J, Ren Y, Tian M, et al
    The value of clinical parameters in predicting the severity of COVID-19.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26031.
    PubMed     Abstract available


  532. BRENNER SR
    The Potential of Memantine and related adamantanes such as amantadine, to reduce the neurotoxic effects of COVID-19, including ARDS and to reduce viral replication through lysosomal effects.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26030.
    PubMed     Abstract available


  533. ANTWI-AMOABENG D, Kanji Z, Ford B, Beutler BD, et al
    Clinical Outcomes in COVID-19 Patients Treated with Tocilizumab: An Individual Patient Data Systematic Review.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26038.
    PubMed     Abstract available


  534. BENKOVIC S, Kim M, Sin E
    4 Cases: HIV and SARS-CoV-2 Co-infection in patients from Long Island, New York.
    J Med Virol. 2020 May 19. doi: 10.1002/jmv.26029.
    PubMed     Abstract available


  535. ZAYET S, Ben Abdallah Y, Royer PY, Toko-Tchiundzie L, et al
    Encephalopathy in patients with COVID-19: 'Causality or coincidence?'
    J Med Virol. 2020 May 19. doi: 10.1002/jmv.26027.
    PubMed     Abstract available


  536. COEN M, Allali G, Adler D, Serratrice J, et al
    Hypoxemia in COVID-19; Comment on: "The neuroinvasive potential of SARS - CoV2 may play a role in the respiratory failure of COVID-19 patients".
    J Med Virol. 2020 May 17. doi: 10.1002/jmv.26020.
    PubMed     Abstract available


  537. CUI X, Zhang T, Zheng J, Zhang J, et al
    Children with Coronavirus Disease 2019 (COVID-19): A Review of Demographic, Clinical, Laboratory and Imaging Features in 2,597 Pediatric Patients.
    J Med Virol. 2020 May 17. doi: 10.1002/jmv.26023.
    PubMed     Abstract available


  538. HASHEMI SA, Safamanesh S, Ghafouri M, Taghavi MR, et al
    Co-infection with COVID-19 and Influenza A Virus in two died patients with Acute Respiratory Syndrome, Bojnurd, Iran.
    J Med Virol. 2020 May 15. doi: 10.1002/jmv.26014.
    PubMed     Abstract available


  539. ODJIDJA EN, Longo VL, Rizzatti G, Bandoh S, et al
    Coronavirus Disease 2019 and Viral Hepatitis coinfection: Provide guidelines for integrated screening and treatment.
    J Med Virol. 2020 May 15. doi: 10.1002/jmv.26021.
    PubMed     Abstract available


  540. YANG P, Wang P, Song Y, Zhang A, et al
    A retrospective study on the epidemiological characteristics and establishment of early warning system of severe COVID-19 patients.
    J Med Virol. 2020 May 15. doi: 10.1002/jmv.26022.
    PubMed     Abstract available


  541. ZHENG Y, Li R, Liu S
    Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines.
    J Med Virol. 2020 May 15. doi: 10.1002/jmv.26009.
    PubMed     Abstract available


  542. CAO H, Ruan L, Liu J, Liao W, et al
    The clinical characteristic of eight patients of COVID-19 with positive RT-PCR test after discharge.
    J Med Virol. 2020 May 15. doi: 10.1002/jmv.26017.
    PubMed     Abstract available


  543. DIOTALLEVI F, Campanati A, Bianchelli T, Bobyr I, et al
    Skin Involvement in SARS-CoV-2 Infection: Case Series.
    J Med Virol. 2020 May 15. doi: 10.1002/jmv.26012.
    PubMed     Abstract available


  544. MUTNAL MB, Arroliga AC, Walker K, Mohammad A, et al
    Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses.
    J Med Virol. 2020 May 15. doi: 10.1002/jmv.26010.
    PubMed     Abstract available


  545. MAZZITELLI M, Arrighi E, Serapide F, Pelle MC, et al
    Use of subcutaneous tocilizumab in patients with COVID-19 pneumonia.
    J Med Virol. 2020 May 15. doi: 10.1002/jmv.26016.
    PubMed     Abstract available


  546. CASTELLS M, Lopez-Tort F, Colina R, Cristina J, et al
    Evidence of Increasing Diversification of Emerging SARS-CoV-2 Strains.
    J Med Virol. 2020 May 15. doi: 10.1002/jmv.26018.
    PubMed     Abstract available


  547. WANG Y, Shi L, Yang H, Duan G, et al
    Acute kidney injury is associated with the mortality of Coronavirus Disease 2019.
    J Med Virol. 2020 May 15. doi: 10.1002/jmv.26019.
    PubMed     Abstract available


  548. HUANG J, Cheng A, Kumar R, Fang Y, et al
    Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity.
    J Med Virol. 2020 May 14. doi: 10.1002/jmv.26003.
    PubMed     Abstract available


  549. KIPKORIR V, Cheruiyot I, Ngure B, Misiani M, et al
    Prolonged SARS-Cov-2 RNA Detection in Anal/Rectal Swabs and Stool Specimens in COVID-19 Patients After Negative Conversion in Nasopharyngeal RT-PCR Test.
    J Med Virol. 2020 May 13. doi: 10.1002/jmv.26007.
    PubMed     Abstract available


  550. CHONG VH, Chong PL, Metussin D, Asli R, et al
    Conduction abnormalities in hydroxychloroquine add on therapy to lopinavir/ritonavir in COVID-19.
    J Med Virol. 2020 May 13. doi: 10.1002/jmv.26004.
    PubMed     Abstract available


  551. CHEN M, An W, Xia F, Yang P, et al
    Clinical Characteristics of Re-hospitalized Patients with COVID-19 in China.
    J Med Virol. 2020 May 13. doi: 10.1002/jmv.26002.
    PubMed     Abstract available


  552. WU Q, Chen T, Zhang H
    Recovery from COVID-19 in two patients with coexisted HIV infection.
    J Med Virol. 2020 May 13. doi: 10.1002/jmv.26006.
    PubMed     Abstract available


  553. FINSTERER J, Stollberger C
    Update on the neurology of COVID-19.
    J Med Virol. 2020 May 13. doi: 10.1002/jmv.26000.
    PubMed     Abstract available


  554. POTERICO JA, Mestanza O
    Genetic variants and source of introduction of SARS-CoV-2 in South America.
    J Med Virol. 2020 May 13. doi: 10.1002/jmv.26001.
    PubMed     Abstract available


  555. WACHARAPLUESADEE S, Kaewpom T, Ampoot W, Ghai S, et al
    Evaluating the efficiency of specimen pooling for PCR-based detection of COVID-19.
    J Med Virol. 2020 May 13. doi: 10.1002/jmv.26005.
    PubMed     Abstract available


  556. JIANG G, Cai Y, Yi X, Li Y, et al
    The impact of laryngopharyngeal reflux disease on 95 hospitalized patients with COVID-19 in Wuhan, China: A retrospective study.
    J Med Virol. 2020 May 12. doi: 10.1002/jmv.25998.
    PubMed     Abstract available


  557. CHAKRABORTY C, Sharma AR, Bhattacharya M, Sharma G, et al
    Consider TLR5 for new therapeutic development against COVID-19.
    J Med Virol. 2020 May 11. doi: 10.1002/jmv.25997.
    PubMed     Abstract available


  558. ZHENG Z, Yao Z, Wu K, Zheng J, et al
    Patient Follow-up after Discharge after COVID-19 Pneumonia: Considerations for Infectious Control.
    J Med Virol. 2020 May 8. doi: 10.1002/jmv.25994.
    PubMed     Abstract available


  559. CHOUDHURY A, Mukherjee S
    In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
    J Med Virol. 2020 May 8. doi: 10.1002/jmv.25987.
    PubMed     Abstract available


  560. CHEN S, Lu H, Liu Z, Yuan W, et al
    Comment on "Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2)".
    J Med Virol. 2020 May 8. doi: 10.1002/jmv.25991.
    PubMed     Abstract available


  561. MANENTI A, Maggetti M, Casa E, Martinuzzi D, et al
    Evaluation of SARS-CoV-2 neutralizing antibodies using of a CPE-based Colorimetric live virus micro-neutralization assay in human serum samples.
    J Med Virol. 2020 May 8. doi: 10.1002/jmv.25986.
    PubMed     Abstract available


  562. ZENG F, Dai C, Cai P, Wang J, et al
    A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between sex.
    J Med Virol. 2020 May 8. doi: 10.1002/jmv.25989.
    PubMed     Abstract available


  563. DRAME M, Teguo MT, Proye E, Hequet F, et al
    Should RT-PCR be considered a gold standard in the diagnosis of Covid-19?
    J Med Virol. 2020 May 8. doi: 10.1002/jmv.25996.
    PubMed     Abstract available


  564. PUJADAS E, Ibeh N, Hernandez MM, Waluszko A, et al
    Comparison of SARS-CoV-2 Detection from Nasopharyngeal Swab Samples by the Roche cobas(R) 6800 SARS-CoV-2 Test and a Laboratory-Developed Real-Time RT-PCR test.
    J Med Virol. 2020 May 8. doi: 10.1002/jmv.25988.
    PubMed     Abstract available


  565. DE MARIA A, Varese P, Dentone C, Barisione E, et al
    High prevalence of olfactory and taste disorder during SARS-CoV-2 infection in outpatients.
    J Med Virol. 2020 May 8. doi: 10.1002/jmv.25995.
    PubMed     Abstract available


  566. WANG Y, Kang H, Liu X, Tong Z, et al
    Asymptomatic Cases with SARS-CoV-2 Infection.
    J Med Virol. 2020 May 8. doi: 10.1002/jmv.25990.
    PubMed     Abstract available


  567. GONG Y, Wen G, Jiang J, Feng X, et al
    Complete title: Codon bias analysis may be insufficient for identifying host(s) of a novel virus.
    J Med Virol. 2020 May 7. doi: 10.1002/jmv.25977.
    PubMed     Abstract available


  568. JAKHAR R, Kaushik S, Gakhar SK
    3CL Hydrolase Based Multi Epitope Peptide Vaccine Against Sars-CoV-2 Using Immunoinformatics.
    J Med Virol. 2020 May 7. doi: 10.1002/jmv.25993.
    PubMed     Abstract available


  569. PUERTAS RR
    ACE2 Activators for the Treatment of Covid 19 Patients.
    J Med Virol. 2020 May 7. doi: 10.1002/jmv.25992.
    PubMed     Abstract available


  570. QIAN J, Feng Y, Li J
    Comments on "Cross-species transmission of the newly identified coronavirus 2019-nCoV".
    J Med Virol. 2020 May 6. doi: 10.1002/jmv.25983.
    PubMed     Abstract available


  571. MUSARRAT F, Chouljenko V, Dahal A, Nabi R, et al
    The anti-HIV Drug Nelfinavir Mesylate (Viracept) is a Potent Inhibitor of Cell Fusion Caused by the SARS-CoV-2 Spike (S) Glycoprotein Warranting further Evaluation as an Antiviral against COVID-19 infections.
    J Med Virol. 2020 May 6. doi: 10.1002/jmv.25985.
    PubMed     Abstract available


  572. DABRAVOLSKI SA, Kavalionak YK
    SARS-CoV-2: Spike glycoprotein structural diversity, phylogeny and potential animal host identification.
    J Med Virol. 2020 May 6. doi: 10.1002/jmv.25976.
    PubMed     Abstract available


  573. BRUFSKY A, Lotze MT
    DC/L-SIGNs of Hope in the COVID-19 Pandemic.
    J Med Virol. 2020 May 6. doi: 10.1002/jmv.25980.
    PubMed     Abstract available


  574. LANGE C, Wolf J, Auw-Haedrich C, Schlecht A, et al
    Expression of the COVID-19 receptor ACE2 in the human conjunctiva.
    J Med Virol. 2020 May 6. doi: 10.1002/jmv.25981.
    PubMed     Abstract available


  575. CALO LA, Davis PA, Rigato M, Sgarabotto L, et al
    ACE2 and prognosis of COVID-19. Insights from Bartter's and Gitelman's syndromes patients.
    J Med Virol. 2020 May 6. doi: 10.1002/jmv.25978.
    PubMed     Abstract available


  576. LIU J, Liu S
    The management of coronavirus disease 2019 (COVID-19).
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25965.
    PubMed     Abstract available


  577. QIU C, Deng Z, Xiao Q, Shu Y, et al
    Transmission and clinical characteristics of coronavirus disease 2019 in 104 outside-Wuhan patients, China.
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25975.
    PubMed     Abstract available


  578. FU W, Chen Q, Wang T
    Letter to the Editor: Three cases of re-detectable positive SARS-CoV-2 RNA in recovered COVID-19 patients with antibodies.
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25968.
    PubMed     Abstract available


  579. FROLDI G
    What could be the better choice between ACE inhibitors and AT1R antagonists in coronavirus disease 2019 (COVID-19) patients?
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25974.
    PubMed     Abstract available


  580. YANG F, Shi S, Zhu J, Shi J, et al
    Clinical characteristics and outcomes of cancer patients with COVID-19.
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25972.
    PubMed     Abstract available


  581. SUN L, Shen L, Fan J, Gu F, et al
    Clinical Features of Patients with Coronavirus Disease 2019 (COVID-19) from a Designated Hospital in Beijing, China.
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25966.
    PubMed     Abstract available


  582. HUANG J, Cheng A, Lin S, Zhu Y, et al
    Individualized prediction nomograms for disease progression in mild COVID-19.
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25969.
    PubMed     Abstract available


  583. LI Y, Xiao SY
    Hepatic involvement in COVID-19 patients: pathology, pathogenesis and clinical implications [Review].
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25973.
    PubMed     Abstract available


  584. GUO FR
    Smoking links to the severity of Covid-19: An update of a meta-analysis.
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25967.
    PubMed     Abstract available


  585. TORRES I, Albert E, Navarro D
    Pooling of Nasopharyngeal Swab Specimens for SARS-CoV-2 detection by RT-PCR.
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25971.
    PubMed     Abstract available


  586. ALATTAR R, Ibrahim TBH, Shaar SH, Abdalla S, et al
    Tocilizumab for the Treatment of Severe COVID-19.
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25964.
    PubMed     Abstract available


  587. RAJENDRAN K, Narayanasamy K, Rangarajan J, Rathinam J, et al
    Convalescent plasma transfusion for the treatment of COVID-19: Systematic review.
    J Med Virol. 2020 May 1. doi: 10.1002/jmv.25961.
    PubMed     Abstract available


  588. DU SQ, Yuan W
    Mathematical Modeling of Interaction between Innate and Adaptive Immune Responses in COVID-19 and Implications for Viral Pathogenesis.
    J Med Virol. 2020 May 1. doi: 10.1002/jmv.25866.
    PubMed     Abstract available


  589. GORSE GJ, Donovan MM, Patel GB
    Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses.
    J Med Virol. 2020;92:512-517.
    PubMed     Abstract available


    April 2020
  590. MEHAN A, Venkatesh A, Girish M
    COVID-19 in pregnancy: risk of adverse neonatal outcomes.
    J Med Virol. 2020 Apr 30. doi: 10.1002/jmv.25959.
    PubMed     Abstract available


  591. CHIGR F, Merzouki M, Najimi M
    Comment on "The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients".
    J Med Virol. 2020 Apr 30. doi: 10.1002/jmv.25960.
    PubMed     Abstract available


  592. NOWAK MD, Sordillo EM, Gitman MR, Paniz Mondolfi AE, et al
    Co-infection in SARS-CoV-2 infected Patients: Where Are Influenza Virus and Rhinovirus/Enterovirus?
    J Med Virol. 2020 Apr 30. doi: 10.1002/jmv.25953.
    PubMed     Abstract available


  593. LI N, Wang X, Lv T
    Prolonged SARS-CoV-2 RNA shedding: Not a rare phenomenon.
    J Med Virol. 2020 Apr 29. doi: 10.1002/jmv.25952.
    PubMed     Abstract available


  594. ALTUNTAS AYDIN O, Kumbasar Karaosmanoglu H, Kart Yasar K
    HIV/SARS-CoV-2 co-infected patients in Istanbul, Turkey.
    J Med Virol. 2020 Apr 29. doi: 10.1002/jmv.25955.
    PubMed     Abstract available


  595. EL-ARABEY AA, Abdalla M
    Metformin and COVID-19: A novel deal of an Old Drug.
    J Med Virol. 2020 Apr 29. doi: 10.1002/jmv.25958.
    PubMed     Abstract available


  596. WEI X, Su J, Yang K, Wei J, et al
    Elevations of serum cancer biomarkers correlate with severity of COVID-19.
    J Med Virol. 2020 Apr 29. doi: 10.1002/jmv.25957.
    PubMed     Abstract available


  597. LU H, Stratton CW, Tang YW
    An Evolving Approach to the Laboratory Assessment of COVID-19.
    J Med Virol. 2020 Apr 29. doi: 10.1002/jmv.25954.
    PubMed     Abstract available


  598. ALI M, Zaid M, Saqib MAN, Ahmed H, et al
    SARS-CoV-2 and the Hidden Carriers - Sewage, Feline, and Blood Transfusion.
    J Med Virol. 2020 Apr 28. doi: 10.1002/jmv.25956.
    PubMed     Abstract available


  599. XU T, Huang R, Zhu L, Wang J, et al
    Epidemiological and clinical features of asymptomatic patients with SARS-CoV-2 infection.
    J Med Virol. 2020 Apr 28. doi: 10.1002/jmv.25944.
    PubMed     Abstract available


  600. AZIZ M, Fatima R, Assaly R
    Elevated Interleukin-6 and Severe COVID-19: A Meta-Analysis.
    J Med Virol. 2020 Apr 28. doi: 10.1002/jmv.25948.
    PubMed     Abstract available


  601. LIU SF, Kuo NY, Kuo HC
    Three Taiwan's domestic family cluster infections of coronavirus disease 2019.
    J Med Virol. 2020 Apr 28. doi: 10.1002/jmv.25949.
    PubMed     Abstract available


  602. STRICKER RB, Fesler MC
    A Novel Plan to Deal with SARS-CoV-2 and COVID-19 Disease.
    J Med Virol. 2020 Apr 28. doi: 10.1002/jmv.25945.
    PubMed     Abstract available


  603. YUAN Y, Qiu T, Wang T, Zhou J, et al
    The application of Temporary Ark Hospitals in controlling COVID-19 spread: the experiences of one Temporary Ark Hospital, Wuhan, China.
    J Med Virol. 2020 Apr 28. doi: 10.1002/jmv.25947.
    PubMed     Abstract available


  604. WANG B, Wang L, Kong X, Geng J, et al
    Long-term Coexistence of SARS-CoV-2 with Antibody Response in COVID-19 Patients.
    J Med Virol. 2020 Apr 28. doi: 10.1002/jmv.25946.
    PubMed     Abstract available


  605. RUBEL AR, Chong PL, Abdullah MS, Asli R, et al
    Letter to the Editor: Lipemic serum in patients with COVID-19 undergoing treatment.
    J Med Virol. 2020 Apr 28. doi: 10.1002/jmv.25942.
    PubMed     Abstract available


  606. HE G, Wu J, Shi J, Dai J, et al
    COVID-19 in Tuberculosis patients: a report of three cases.
    J Med Virol. 2020 Apr 28. doi: 10.1002/jmv.25943.
    PubMed     Abstract available


  607. LU D, Sang L, Du S, Li T, et al
    Asymptomatic COVID-19 infection in late pregnancy indicated no vertical transmission.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25927.
    PubMed     Abstract available


  608. TRIPATHY JP
    Does pandemic justify the use of Hydroxychloroquine for treatment and prevention of COVID-19 in India?
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25933.
    PubMed     Abstract available


  609. JIANG X, Luo M, Zou Z, Wang X, et al
    Asymptomatic SARS-CoV-2 infected case with viral detection positive in stool but negative in nasopharyngeal samples lasts for 42 days.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25941.
    PubMed     Abstract available


  610. PENG L, Liu J, Xu W, Luo Q, et al
    SARS-CoV-2 can be detected in urine, blood, anal swabs and oropharyngeal swabs specimens.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25936.
    PubMed     Abstract available


  611. LOFFREDO L, Pacella F, Pacella E, Tiscione G, et al
    Conjunctivitis and COVID-19: a meta-analysis.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25938.
    PubMed     Abstract available


  612. XIE J, Ding C, Li J, Wang Y, et al
    Characteristics of Patients with Coronavirus Disease (COVID-19) Confirmed using an IgM-IgG Antibody Test.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25930.
    PubMed     Abstract available


  613. HU S
    Comment on "Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19".
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25937.
    PubMed     Abstract available


  614. SUN T, Weng D
    Estimating the Effects of Asymptomatic and Imported Patients on COVID-19 Epidemic Using Mathematical Modeling.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25939.
    PubMed     Abstract available


  615. ARAGON-CAQUEO D, Fernandez-Salinas J, Laroze D
    Optimization of group size in pool testing strategy for SARS-CoV-2: A simple mathematical model.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25929.
    PubMed     Abstract available


  616. LI BZ, Cao NW, Zhou HY, Chu XJ, et al
    Strong policies control the spread of COVID-19 in China.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25934.
    PubMed     Abstract available


  617. YANG JR, Deng DT, Wu N, Yang B, et al
    Persistent viral RNA positivity during recovery period of a patient with SARS-CoV-2 infection.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25940.
    PubMed     Abstract available


  618. INFANTINO M, Grossi V, Lari B, Bambi R, et al
    Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25932.
    PubMed     Abstract available


  619. HOSEINPOUR DEHKORDI A, Alizadeh M, Derakhshan P, Babazadeh P, et al
    Understanding epidemic data and statistics: A case study of COVID-19.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25885.
    PubMed     Abstract available


  620. LONG-QUAN L, Tian H, Yong-Qing W, Zheng-Ping W, et al
    Response to Char's comment: Comment on Li et al.: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.
    J Med Virol. 2020 Apr 22. doi: 10.1002/jmv.25924.
    PubMed     Abstract available


  621. MA QX, Shan H, Zhang CM, Zhang HL, et al
    Decontamination of face masks with steam for mask reuse in fighting the pandemic COVID-19: experimental supports.
    J Med Virol. 2020 Apr 22. doi: 10.1002/jmv.25921.
    PubMed     Abstract available


  622. BLASCO ML, Buesa J, Colomina J, Forner MJ, et al
    Co-detection of respiratory pathogens in patients hospitalized with Coronavirus viral disease-2019 pneumonia.
    J Med Virol. 2020 Apr 22. doi: 10.1002/jmv.25922.
    PubMed     Abstract available


  623. YASHAVANTHA RAO HC, Jayabaskaran C
    The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients.
    J Med Virol. 2020 Apr 22. doi: 10.1002/jmv.25918.
    PubMed     Abstract available


  624. YONG G, Yi Y, Tuantuan L, Xiaowu W, et al
    Evaluation of the auxiliary diagnostic value of antibody assays for the detection of novel coronavirus (SARS-CoV-2).
    J Med Virol. 2020 Apr 22. doi: 10.1002/jmv.25919.
    PubMed     Abstract available


  625. HARA T, Yamamoto C, Sawada R, Ohara T, et al
    Infection risk in a gastroenterological ward during a nosocomial COVID-19 infection event.
    J Med Virol. 2020 Apr 22. doi: 10.1002/jmv.25853.
    PubMed     Abstract available


  626. CHEN JW, Chen JM
    Potential of live pathogen vaccines for defeating the COVID-19 pandemic: history and mechanism.
    J Med Virol. 2020 Apr 22. doi: 10.1002/jmv.25920.
    PubMed     Abstract available


  627. YU Y, Shi Q, Zheng P, Gao L, et al
    Assessment of the quality of systematic reviews on COVID-19: A comparative study of previous coronavirus outbreaks.
    J Med Virol. 2020 Apr 17. doi: 10.1002/jmv.25901.
    PubMed     Abstract available


  628. LAGUNAS-RANGEL FA, Chavez-Valencia V
    High IL-6/IFN-gamma ratio could be associated with severe disease in COVID-19 patients.
    J Med Virol. 2020 Apr 16. doi: 10.1002/jmv.25900.
    PubMed     Abstract available


  629. SARMA P, Kaur H, Kumar H, Mahendru D, et al
    Virological and Clinical Cure in Covid-19 Patients Treated with Hydroxychloroquine: A Systematic Review and Meta-Analysis.
    J Med Virol. 2020 Apr 16. doi: 10.1002/jmv.25898.
    PubMed     Abstract available


  630. DI GIAMBENEDETTO S, Ciccullo A, Borghetti A, Gambassi G, et al
    Off-label Use of Tocilizumab in Patients with SARS-CoV-2 Infection.
    J Med Virol. 2020 Apr 16. doi: 10.1002/jmv.25897.
    PubMed     Abstract available


  631. SHI X, Lu Y, Li R, Tang Y, et al
    Evaluation of Antiviral Therapies for Coronavirus Disease 2019 (COVID-19) Pneumonia in Shanghai, China.
    J Med Virol. 2020 Apr 16. doi: 10.1002/jmv.25893.
    PubMed     Abstract available


  632. GIANGRECO G
    Case fatality rate analysis of Italian COVID-19 outbreak.
    J Med Virol. 2020 Apr 16. doi: 10.1002/jmv.25894.
    PubMed     Abstract available


  633. SONG F, Zhang X, Zha Y, Liu W, et al
    COVID-19: Recommended sampling sites at different stage of the disease.
    J Med Virol. 2020 Apr 16. doi: 10.1002/jmv.25892.
    PubMed     Abstract available


  634. KHOSRAWIPOUR V, Lau H, Khosrawipour T, Kocbach P, et al
    Failure in initial stage containment of global COVID-19 epicenters.
    J Med Virol. 2020 Apr 16. doi: 10.1002/jmv.25883.
    PubMed     Abstract available


  635. ZHAO Q, Meng M, Kumar R, Wu Y, et al
    The impact of COPD and smoking history on the severity of Covid-19: A systemic review and meta-analysis.
    J Med Virol. 2020 Apr 15. doi: 10.1002/jmv.25889.
    PubMed     Abstract available


  636. CHAUNG J, Chan D, Pada S, Tambyah PA, et al
    Coinfection with COVID-19 and Coronavirus HKU1 - the critical need for repeat testing if clinically indicated.
    J Med Virol. 2020 Apr 15. doi: 10.1002/jmv.25890.
    PubMed     Abstract available


  637. YANG F, Shi S, Zhu J, Shi J, et al
    Analysis of 92 deceased patients with COVID-19.
    J Med Virol. 2020 Apr 15. doi: 10.1002/jmv.25891.
    PubMed     Abstract available


  638. ZHU J, Ji P, Pang J, Zhong Z, et al
    Clinical characteristics of 3,062 COVID-19 patients: a meta-analysis.
    J Med Virol. 2020 Apr 15. doi: 10.1002/jmv.25884.
    PubMed     Abstract available


  639. YIN R, Feng W, Wang T, Chen G, et al
    Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019.
    J Med Virol. 2020 Apr 15. doi: 10.1002/jmv.25888.
    PubMed     Abstract available


  640. YE M, Fu D, Ren Y, Wang F, et al
    Treatment with convalescent plasma for COVID-19 patients in Wuhan, China.
    J Med Virol. 2020 Apr 15. doi: 10.1002/jmv.25882.
    PubMed     Abstract available


  641. HAN G, Zhou YH
    Possibly critical role of wearing masks in general population in controlling COVID-19.
    J Med Virol. 2020 Apr 15. doi: 10.1002/jmv.25886.
    PubMed     Abstract available


  642. BRUFSKY A
    Hyperglycemia, Hydroxychloroquine, and the COVID-19 Epidemic.
    J Med Virol. 2020 Apr 15. doi: 10.1002/jmv.25887.
    PubMed     Abstract available


  643. MASCOLO S, Romanelli A, Carleo MA, Esposito V, et al
    Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better.
    J Med Virol. 2020 Apr 15. doi: 10.1002/jmv.25881.
    PubMed     Abstract available


  644. DE ANGEL SOLA DE, Wang L, Vazquez M, Mendez Lazaro PA, et al
    Weathering the pandemic: How the Caribbean Basin can use viral and environmental patterns to predict, prepare and respond to COVID-19.
    J Med Virol. 2020 Apr 10. doi: 10.1002/jmv.25864.
    PubMed     Abstract available


  645. LIU Z, Sun CB
    Conjunctiva is not a preferred gateway of entry for SARS-CoV-2 to infect respiratory tract.
    J Med Virol. 2020 Apr 10. doi: 10.1002/jmv.25859.
    PubMed     Abstract available


  646. PU T, Ding C, Li Y, Liu X, et al
    Evaluate Severe Acute Respiratory Syndrome Coronavirus 2 Infectivity by Pseudoviral Particles.
    J Med Virol. 2020 Apr 10. doi: 10.1002/jmv.25865.
    PubMed     Abstract available


  647. GUO D, Xia J, Shen Y, Tong J, et al
    SARS-CoV-2 may be related to conjunctivitis but not necessarily spread through the conjunctiva SARS-CoV-2 and conjunctiva.
    J Med Virol. 2020 Apr 10. doi: 10.1002/jmv.25856.
    PubMed     Abstract available


  648. LIPPI G, Mattiuzzi C, Sanchis-Gomar F, Henry BM, et al
    Clinical and demographic characteristics of patients dying from COVID-19 in Italy versus China.
    J Med Virol. 2020 Apr 10. doi: 10.1002/jmv.25860.
    PubMed     Abstract available


  649. HE G, Sun W, Fang P, Huang J, et al
    The clinical feature of silent infections of novel coronavirus infection (COVID-19) in Wenzhou.
    J Med Virol. 2020 Apr 10. doi: 10.1002/jmv.25861.
    PubMed     Abstract available


  650. CICCOZZI M, Benvenuto D, Giovanetti M, Bianchi M, et al
    Response to Ribeiro da Silva et al.,"Role of Nonstructural Proteins in the Pathogenesis of SARS-CoV-2.
    J Med Virol. 2020 Apr 10. doi: 10.1002/jmv.25863.
    PubMed     Abstract available


  651. XIONG X, Wei H, Zhang Z, Chang J, et al
    Vaginal Delivery Report of a Healthy Neonate Born to a Convalescent Mother with COVID-19.
    J Med Virol. 2020 Apr 10. doi: 10.1002/jmv.25857.
    PubMed     Abstract available


  652. DA SILVA SJR, da Silva CTA, Mendes RPG, Pena L, et al
    Role of Nonstructural Proteins in the Pathogenesis of SARS-CoV-2.
    J Med Virol. 2020 Apr 9. doi: 10.1002/jmv.25858.
    PubMed     Abstract available


  653. XIAO AT, Tong YX, Zhang S
    False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence.
    J Med Virol. 2020 Apr 9. doi: 10.1002/jmv.25855.
    PubMed     Abstract available


  654. AL-ROUSAN N, Al-Najjar H
    Data Analysis of Coronavirus CoVID-19 Epidemic in South Korea Based on Recovered and Death Cases.
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25850.
    PubMed     Abstract available


  655. HADADI A, Mortezazadeh M, Kolahdouzan K, Alavian G, et al
    Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25839.
    PubMed     Abstract available


  656. CHEN D, Li Y, Deng X, Huang H, et al
    Four cases from a family cluster were diagnosed as COVID-19 after 14-day of quarantine period.
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25849.
    PubMed     Abstract available


  657. AHMED AE
    Limited transmissibility of coronavirus (SARS-1, MERS, and SARS-2) in certain regions of Africa.
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25852.
    PubMed     Abstract available


  658. ZHOU ZG, Yue DS, Mu CL, Zhang L, et al
    Mask is the possible key for self-isolation in COVID-19 pandemic.
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25846.
    PubMed     Abstract available


  659. MISHRA AK, Sahu KK, Lal A, Sargent J, et al
    Patterns of heart Injury in COVID - 19 and relation to outcome.
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25847.
    PubMed     Abstract available


  660. ZHU F, Cao Y, Xu S, Zhou M, et al
    Reply to Comments on 'Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China'.
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25838.
    PubMed     Abstract available


  661. CURE E, Cumhur Cure M
    Comment on "Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19".
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25848.
    PubMed     Abstract available


  662. MISHRA AK, Sahu KK, Lal A
    Reporting of all cardiac medications and their outcome in COVID - 19.
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25843.
    PubMed     Abstract available


  663. QAZI A, Qazi J, Naseer K, Zeeshan M, et al
    Analyzing Situational Awareness through Public Opinion to Predict Adoption of Social Distancing Amid Pandemic COVID-19.
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25840.
    PubMed     Abstract available


  664. LUO P, Liu Y, Qiu L, Liu X, et al
    Tocilizumab treatment in COVID-19: a single center experience.
    J Med Virol. 2020 Apr 6. doi: 10.1002/jmv.25801.
    PubMed     Abstract available


  665. DU Z, Zhu F, Guo F, Yang B, et al
    Detection of antibodies against SARS-CoV-2 in patients with COVID-19.
    J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25820.
    PubMed     Abstract available


  666. CHEN Y, Chen L, Deng Q, Zhang G, et al
    The Presence of SARS-CoV-2 RNA in Feces of COVID-19 Patients.
    J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25825.
    PubMed     Abstract available


  667. HOU C, Chen J, Zhou Y, Hua L, et al
    The effectiveness of the quarantine of Wuhan city against the Corona Virus Disease 2019 (COVID-19): well-mixed SEIR model analysis.
    J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25827.
    PubMed     Abstract available


  668. CORACI D, Fusco A, Frizziero A, Giovannini S, et al
    Global approaches for global challenges: the possible support of rehabilitation in the management of COVID-19.
    J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25829.
    PubMed     Abstract available


  669. OKYERE MA, Forson R, Essel-Gaisey F
    Positive Externalities of an Epidemic: The Case of the Corona Virus (COVID-19) in China.
    J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25830.
    PubMed     Abstract available


  670. LAGUNAS-RANGEL FA
    Neutrophil-to-Lymphocyte ratio and Lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.
    J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25819.
    PubMed     Abstract available


  671. CICCOZZI M, Giovanetti M, Benvenuto D, Angeletti S, et al
    Response to Carletti et al., "About the origin of the first two Sars-CoV-2 infections in Italy: inference not supported by appropriate sequence analysis."
    J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25823.
    PubMed     Abstract available


  672. CAO Y, Liu X, Xiong L, Cai K, et al
    Imaging and Clinical Features of Patients With 2019 Novel Coronavirus SARS-CoV-2: A systematic review and meta-analysis.
    J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25822.
    PubMed     Abstract available


  673. NIXON DF
    Comments on 'Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China'.
    J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25821.
    PubMed     Abstract available


  674. SUN P, Ren J, Li K, Qie S, et al
    Response to: Sore throat in COVID-19: comment on "Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis".
    J Med Virol. 2020 Apr 2. doi: 10.1002/jmv.25818.
    PubMed     Abstract available


  675. LUAN J, Jin X, Lu Y, Zhang L, et al
    SARS-CoV-2 spike protein favors ACE2 from Bovidae and Cricetidae.
    J Med Virol. 2020 Apr 1. doi: 10.1002/jmv.25817.
    PubMed     Abstract available


  676. NOURI-VASKEH M, Alizadeh L
    Fecal Transmission in COVID-19: A Potential Shedding Rout.
    J Med Virol. 2020 Apr 1. doi: 10.1002/jmv.25816.
    PubMed     Abstract available


  677. YU Y, Shi Q, Chen H
    Comments on Zhang et al.: Clinical trial analysis of 2019-nCoV therapy registered in China.
    J Med Virol. 2020 Apr 1. doi: 10.1002/jmv.25806.
    PubMed     Abstract available


  678. LOVATO A, Rossettini G, de Filippis C
    Sore throat in COVID-19: comment on "Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis".
    J Med Virol. 2020 Apr 1. doi: 10.1002/jmv.25815.
    PubMed     Abstract available


  679. KHAN S, Khan M, Maqsood K, Hussain T, et al
    Is Pakistan prepared for the COVID-19 epidemic? A questionnaire-based survey.
    J Med Virol. 2020 Apr 1. doi: 10.1002/jmv.25814.
    PubMed     Abstract available


  680. YE Q, Wang B, Mao J, Fu J, et al
    Epidemiological analysis of COVID-19 and practical experience from China.
    J Med Virol. 2020 Apr 1. doi: 10.1002/jmv.25813.
    PubMed     Abstract available


  681. CHEN X, Yang Y, Huang M, Liu L, et al
    Differences between COVID-19 and suspected then confirmed SARS-CoV-2-negative pneumonia: a retrospective study from a single center.
    J Med Virol. 2020 Apr 1. doi: 10.1002/jmv.25810.
    PubMed     Abstract available


    March 2020
  682. MA QX, Shan H, Zhang HL, Li GM, et al
    Potential utilities of mask wearing and instant hand hygiene for fighting SARS-CoV-2.
    J Med Virol. 2020 Mar 31. doi: 10.1002/jmv.25805.
    PubMed     Abstract available


  683. JIATONG S, Lanqin L, Wenjun L
    COVID-19 epidemic: disease characteristics in children.
    J Med Virol. 2020 Mar 31. doi: 10.1002/jmv.25807.
    PubMed     Abstract available


  684. HAN H, Xie L, Liu R, Yang J, et al
    Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China.
    J Med Virol. 2020 Mar 31. doi: 10.1002/jmv.25809.
    PubMed     Abstract available


  685. ZHANG Q, Wang Y, Qi C, Shen L, et al
    Response to "Comments on 'Zhang et al.: Clinical trial analysis of 2019-nCoV therapy registered in China '".
    J Med Virol. 2020 Mar 31. doi: 10.1002/jmv.25803.
    PubMed     Abstract available


  686. SUN P, Lu X, Xu C, Wang Y, et al
    CD-sACE2 Inclusion Compounds: An Effective Treatment for Corona Virus Disease 2019 (COVID-19).
    J Med Virol. 2020 Mar 31. doi: 10.1002/jmv.25804.
    PubMed     Abstract available


  687. YAJUNYUAN, Wang N, Ou X
    Caution should be exercised for the detection of SARS-CoV-2, especially in the elderly.
    J Med Virol. 2020 Mar 30. doi: 10.1002/jmv.25796.
    PubMed     Abstract available


  688. KHALILI JS, Zhu H, Mak A, Yan Y, et al
    Novel coronavirus treatment with ribavirin: Groundwork for evaluation concerning COVID-19.
    J Med Virol. 2020 Mar 30. doi: 10.1002/jmv.25798.
    PubMed     Abstract available


  689. CASSANITI I, Novazzi F, Giardina F, Salivaro F, et al
    Performance of VivaDiagTM COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department.
    J Med Virol. 2020 Mar 30. doi: 10.1002/jmv.25800.
    PubMed     Abstract available


  690. KEMPTON M
    Concerns regarding calculation of fatality rate of Chinese samples in COVID-19 meta-analysis.
    J Med Virol. 2020 Mar 30. doi: 10.1002/jmv.25799.
    PubMed     Abstract available


  691. DENG Z, Yuxing HU, Yang P, Zheng P, et al
    Diagnosis and Treatment of an Acute Severe Pneumonia Patient with COVID-19: Case Report.
    J Med Virol. 2020 Mar 30. doi: 10.1002/jmv.25802.
    PubMed     Abstract available


  692. CASTILLO AE, Parra B, Tapia P, Acevedo A, et al
    Phylogenetic analysis of the first four SARS-CoV-2 cases in Chile.
    J Med Virol. 2020 Mar 29. doi: 10.1002/jmv.25797.
    PubMed     Abstract available


  693. ZEHENDER G, Lai A, Bergna A, Meroni L, et al
    GENOMIC CHARACTERISATION AND PHYLOGENETIC ANALYSIS OF SARS-COV-2 IN ITALY.
    J Med Virol. 2020 Mar 29. doi: 10.1002/jmv.25794.
    PubMed     Abstract available


  694. ZHANG T, Cui X, Zhao X, Wang J, et al
    Detectable SARS-CoV-2 Viral RNA in Feces of Three Children during Recovery Period of COVID-19 Pneumonia.
    J Med Virol. 2020 Mar 29. doi: 10.1002/jmv.25795.
    PubMed     Abstract available


  695. CHU J, Yang N, Wei Y, Yue H, et al
    Clinical Characteristics of 54 medical staff with COVID-19: A retrospective study in a single center in Wuhan, China.
    J Med Virol. 2020 Mar 29. doi: 10.1002/jmv.25793.
    PubMed     Abstract available


  696. CHEN S, Liao E, Shao Y
    Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia.
    J Med Virol. 2020 Mar 28. doi: 10.1002/jmv.25789.
    PubMed     Abstract available


  697. CHENG H, Wang Y, Wang GQ
    Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19.
    J Med Virol. 2020 Mar 27. doi: 10.1002/jmv.25785.
    PubMed     Abstract available


  698. WAN S, Xiang Y, Fang W, Zheng Y, et al
    Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing.
    J Med Virol. 2020 Mar 21. doi: 10.1002/jmv.25783.
    PubMed     Abstract available


  699. DING Q, Lu P, Fan Y, Xia Y, et al
    The clinical characteristics of pneumonia patients co-infected with 2019 novel coronavirus and influenza virus in Wuhan, China.
    J Med Virol. 2020 Mar 20. doi: 10.1002/jmv.25781.
    PubMed     Abstract available


  700. AGYEMAN AA, Laar A, Ofori-Asenso R
    Will COVID-19 be a litmus test for post-Ebola Sub-Saharan Africa?
    J Med Virol. 2020 Mar 20. doi: 10.1002/jmv.25780.
    PubMed     Abstract available


  701. GIOVANETTI M, Angeletti S, Benvenuto D, Ciccozzi M, et al
    A doubt of multiple introduction of SARS-CoV-2 in Italy: a preliminary overview.
    J Med Virol. 2020 Mar 19. doi: 10.1002/jmv.25773.
    PubMed     Abstract available


  702. LU S, Lin J, Zhang Z, Xiao L, et al
    Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients.
    J Med Virol. 2020 Mar 19. doi: 10.1002/jmv.25776.
    PubMed     Abstract available


  703. GAO Y, Li T, Han M, Li X, et al
    Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID-19.
    J Med Virol. 2020 Mar 17. doi: 10.1002/jmv.25770.
    PubMed     Abstract available


  704. JIAO J
    Under the epidemic situation of COVID-19, should special attention to pregnant women be given?
    J Med Virol. 2020 Mar 17. doi: 10.1002/jmv.25771.
    PubMed     Abstract available


  705. QU R, Ling Y, Zhang YH, Wei LY, et al
    Platelet-to-lymphocyte ratio is associated with prognosis in patients with Corona Virus Disease-19.
    J Med Virol. 2020 Mar 17. doi: 10.1002/jmv.25767.
    PubMed     Abstract available


  706. DONG S, Sun J, Mao Z, Wang L, et al
    A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019-nCoV).
    J Med Virol. 2020 Mar 17. doi: 10.1002/jmv.25768.
    PubMed     Abstract available


  707. CIMOLAI N
    Potentially repurposing adamantanes for COVID-19.
    J Med Virol. 2020 Mar 16. doi: 10.1002/jmv.25752.
    PubMed    


  708. PENG Y, Zhou YH
    Is novel coronavirus disease (COVID-19) transmitted through conjunctiva?
    J Med Virol. 2020 Mar 16. doi: 10.1002/jmv.25753.
    PubMed    


  709. HE F, Deng Y, Li W
    Coronavirus Disease 2019 (COVID-19): What we know?
    J Med Virol. 2020 Mar 14. doi: 10.1002/jmv.25766.
    PubMed     Abstract available


  710. ZHU W, Xie K, Lu H, Xu L, et al
    Initial clinical features of suspected Coronavirus Disease 2019 in two emergency departments outside of Hubei, China.
    J Med Virol. 2020 Mar 13. doi: 10.1002/jmv.25763.
    PubMed     Abstract available


  711. WANG C, Liu Z, Chen Z, Huang X, et al
    The establishment of reference sequence for SARS-CoV-2 and variation analysis.
    J Med Virol. 2020 Mar 13. doi: 10.1002/jmv.25762.
    PubMed     Abstract available


  712. LUNG J, Lin YS, Yang YH, Chou YL, et al
    The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase.
    J Med Virol. 2020 Mar 13. doi: 10.1002/jmv.25761.
    PubMed     Abstract available


  713. CARDENAS-CONEJO Y, Linan-Rico A, Garcia-Rodriguez DA, Centeno-Leija S, et al
    An exclusive 42 amino acid signature in pp1ab protein provides insights into the evolutive history of the 2019 novel human-pathogenic coronavirus (SARS-CoV2).
    J Med Virol. 2020 Mar 13. doi: 10.1002/jmv.25758.
    PubMed     Abstract available


  714. LI LQ, Huang T, Wang YQ, Wang ZP, et al
    2019 novel coronavirus patients' clinical characteristics, discharge rate and fatality rate of meta-analysis.
    J Med Virol. 2020 Mar 12. doi: 10.1002/jmv.25757.
    PubMed     Abstract available


  715. CHEN Q, Quan B, Li X, Gao G, et al
    A report of clinical diagnosis and treatment of 9 cases of coronavirus disease 2019.
    J Med Virol. 2020 Mar 12. doi: 10.1002/jmv.25755.
    PubMed     Abstract available


  716. ZHU F, Cao Y, Xu S, Zhou M, et al
    Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China.
    J Med Virol. 2020 Mar 11. doi: 10.1002/jmv.25732.
    PubMed    


  717. KANDEEL M, Ibrahim AA, Fayez M, Al-Nazawi M, et al
    From SARS and MERS CoVs to SARS-CoV-2: moving toward more biased codon usage in viral structural and non-structural genes.
    J Med Virol. 2020 Mar 11. doi: 10.1002/jmv.25754.
    PubMed     Abstract available


  718. CONWAY MJ
    Identification of Coronavirus Sequences in Carp cDNA from Wuhan, China.
    J Med Virol. 2020 Mar 11. doi: 10.1002/jmv.25751.
    PubMed     Abstract available


  719. FANG Y, Nie Y, Penny M
    Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: A data-driven analysis.
    J Med Virol. 2020 Mar 6. doi: 10.1002/jmv.25750.
    PubMed     Abstract available


  720. HAN Y, Yang H
    The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): A Chinese perspective.
    J Med Virol. 2020 Mar 6. doi: 10.1002/jmv.25749.
    PubMed     Abstract available


  721. WANG Y, Wang Y, Chen Y, Qin Q, et al
    Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.
    J Med Virol. 2020 Mar 5. doi: 10.1002/jmv.25748.
    PubMed     Abstract available


  722. ZHANG J, Wang S, Xue Y
    Fecal specimen diagnosis 2019 Novel Coronavirus-Infected Pneumonia.
    J Med Virol. 2020 Mar 3. doi: 10.1002/jmv.25742.
    PubMed     Abstract available


  723. DEY SK, Rahman MM, Siddiqi UR, Howlader A, et al
    Analyzing the Epidemiological Outbreak of COVID-19: A Visual Exploratory Data Analysis (EDA) Approach.
    J Med Virol. 2020 Mar 3. doi: 10.1002/jmv.25743.
    PubMed     Abstract available


  724. LU Q, Shi Y
    Coronavirus disease (COVID-19) and neonate: What neonatologist need to know.
    J Med Virol. 2020 Mar 1. doi: 10.1002/jmv.25740.
    PubMed     Abstract available


  725. LU H, Stratton CW, Tang YW
    The Wuhan SARS-CoV-2 - What's Next for China.
    J Med Virol. 2020 Mar 1. doi: 10.1002/jmv.25738.
    PubMed     Abstract available


    February 2020
  726. BHATTACHARYA M, Ranjan Sharma A, Patra P, Ghosh P, et al
    Development of epitope-based peptide vaccine against novel Coronavirus 2019 (SARS-COV-2): Immunoinformatics approach.
    J Med Virol. 2020 Feb 28. doi: 10.1002/jmv.25736.
    PubMed     Abstract available


  727. ZHANG Q, Wang Y, Qi C, Shen L, et al
    Clinical trial analysis of 2019-nCoV therapy registered in China.
    J Med Virol. 2020 Feb 28. doi: 10.1002/jmv.25733.
    PubMed     Abstract available


  728. SUN P, Qie S, Liu Z, Ren J, et al
    Clinical characteristics of 50466 hospitalized patients with 2019-nCoV infection.
    J Med Virol. 2020 Feb 28. doi: 10.1002/jmv.25735.
    PubMed     Abstract available


  729. LI Z, Yi Y, Luo X, Xiong N, et al
    Development and Clinical Application of A Rapid IgM-IgG Combined Antibody Test for SARS-CoV-2 Infection Diagnosis.
    J Med Virol. 2020 Feb 27. doi: 10.1002/jmv.25727.
    PubMed     Abstract available


  730. LI YC, Bai WZ, Hashikawa T
    The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients.
    J Med Virol. 2020 Feb 27. doi: 10.1002/jmv.25728.
    PubMed     Abstract available


  731. LI X, Zai J, Zhao Q, Nie Q, et al
    Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.
    J Med Virol. 2020 Feb 27. doi: 10.1002/jmv.25731.
    PubMed     Abstract available


  732. YAO TT, Qian JD, Zhu WY, Wang Y, et al
    A Systematic Review of Lopinavir Therapy for SARS Coronavirus and MERS Coronavirus-A Possible Reference for Coronavirus Disease-19 Treatment Option.
    J Med Virol. 2020 Feb 27. doi: 10.1002/jmv.25729.
    PubMed     Abstract available


  733. LIU Z, Xiao X, Wei X, Li J, et al
    Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.
    J Med Virol. 2020 Feb 26. doi: 10.1002/jmv.25726.
    PubMed     Abstract available


  734. XIA J, Tong J, Liu M, Shen Y, et al
    Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection.
    J Med Virol. 2020 Feb 26. doi: 10.1002/jmv.25725.
    PubMed     Abstract available


  735. SUN P, Lu X, Xu C, Sun W, et al
    Understanding of COVID-19 based on current evidence.
    J Med Virol. 2020 Feb 25. doi: 10.1002/jmv.25722.
    PubMed     Abstract available


  736. LAI A, Bergna A, Acciarri C, Galli M, et al
    Early Phylogenetic Estimate of the Effective Reproduction Number Of Sars-CoV-2.
    J Med Virol. 2020 Feb 25. doi: 10.1002/jmv.25723.
    PubMed     Abstract available


  737. WANG Y, Kang H, Liu X, Tong Z, et al
    Combination of RT-qPCR Testing and Clinical Features For Diagnosis of COVID-19 facilitates management of SARS-CoV-2 Outbreak.
    J Med Virol. 2020 Feb 25. doi: 10.1002/jmv.25721.
    PubMed     Abstract available


  738. YANG Y, Shang W, Rao X
    Facing the COVID-19 outbreak: What should we know and what could we do?
    J Med Virol. 2020 Feb 24. doi: 10.1002/jmv.25720.
    PubMed     Abstract available


  739. HAN W, Quan B, Guo Y, Zhang J, et al
    The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019.
    J Med Virol. 2020 Feb 19. doi: 10.1002/jmv.25711.
    PubMed     Abstract available


  740. LIU J, Zheng X, Tong Q, Li W, et al
    Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.
    J Med Virol. 2020 Feb 13. doi: 10.1002/jmv.25709.
    PubMed     Abstract available


  741. JIANG X, Rayner S, Luo MH
    Does SARS-CoV-2 has a longer incubation period than SARS and MERS?
    J Med Virol. 2020 Feb 13. doi: 10.1002/jmv.25708.
    PubMed     Abstract available


  742. ZHANG L, Liu Y
    Potential Interventions for Novel Coronavirus in China: A Systemic Review.
    J Med Virol. 2020 Feb 13. doi: 10.1002/jmv.25707.
    PubMed     Abstract available


  743. GUAN W, Xian J
    The progress of 2019 Novel Coronavirus (2019-nCoV) event in China.
    J Med Virol. 2020 Feb 12. doi: 10.1002/jmv.25705.
    PubMed     Abstract available


  744. AYITTEY FK, Ayittey MK, Chiwero NB, Kamasah JS, et al
    Economic Impacts of Wuhan 2019-nCoV on China and the World.
    J Med Virol. 2020 Feb 12. doi: 10.1002/jmv.25706.
    PubMed     Abstract available


  745. XIAO SY, Wu Y, Liu H
    Evolving status of the 2019 novel coronavirus Infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring [Commentary/Review].
    J Med Virol. 2020 Feb 7. doi: 10.1002/jmv.25702.
    PubMed     Abstract available


  746. CERAOLO C, Giorgi FM
    Genomic variance of the 2019-nCoV coronavirus.
    J Med Virol. 2020 Feb 6. doi: 10.1002/jmv.25700.
    PubMed     Abstract available


  747. LI X, Wang W, Zhao X, Zai J, et al
    Transmission dynamics and evolutionary history of 2019-nCoV.
    J Med Virol. 2020 Feb 6. doi: 10.1002/jmv.25701.
    PubMed     Abstract available


  748. BARUAH V, Bose S
    Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV.
    J Med Virol. 2020 Feb 5. doi: 10.1002/jmv.25698.
    PubMed     Abstract available


  749. GIOVANETTI M, Benvenuto D, Angeletti S, Ciccozzi M, et al
    The first two cases of 2019-nCoV in Italy: where they come from?
    J Med Virol. 2020 Feb 5. doi: 10.1002/jmv.25699.
    PubMed     Abstract available


  750. KOFI AYITTEY F, Dzuvor C, Kormla Ayittey M, Bennita Chiwero N, et al
    Updates on Wuhan 2019 Novel Coronavirus Epidemic.
    J Med Virol. 2020 Feb 4. doi: 10.1002/jmv.25695.
    PubMed     Abstract available


    January 2020
  751. LI X, Zai J, Wang X, Li Y, et al
    Potential of large 'first generation' human-to-human transmission of 2019-nCoV.
    J Med Virol. 2020 Jan 30. doi: 10.1002/jmv.25693.
    PubMed     Abstract available


  752. WANG W, Tang J, Wei F
    Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China.
    J Med Virol. 2020 Jan 29. doi: 10.1002/jmv.25689.
    PubMed     Abstract available


  753. BENVENUTO D, Giovanetti M, Ciccozzi A, Spoto S, et al
    The 2019-new coronavirus epidemic: Evidence for virus evolution.
    J Med Virol. 2020 Jan 29. doi: 10.1002/jmv.25688.
    PubMed     Abstract available


  754. CHEN Y, Liu Q, Guo D
    Emerging coronaviruses: Genome structure, replication, and pathogenesis.
    J Med Virol. 2020 Jan 22. doi: 10.1002/jmv.25681.
    PubMed     Abstract available


  755. JI W, Wang W, Zhao X, Zai J, et al
    Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human.
    J Med Virol. 2020 Jan 22. doi: 10.1002/jmv.25682.
    PubMed     Abstract available


  756. LU H, Stratton CW, Tang YW
    Outbreak of Pneumonia of Unknown Etiology in Wuhan China: the Mystery and the Miracle.
    J Med Virol. 2020 Jan 16. doi: 10.1002/jmv.25678.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO COVID-19 is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: